{
    "paper_id": "7449684ff88a860dd7182cb57067869351d4e49f",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Notes Cross-reference terms in italics are general cross-references, or refer to subentry terms within the main entry (the main entry is not repeated to save space).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Index"
        },
        {
            "text": "The index is arranged in set-out style with a maximum of two levels of subheading. Major discussion of a subject is indicated by bold page numbers. Page numbers suffixed by T and F refer to tables and figures, respectively; vs. indicates a comparison.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Index"
        },
        {
            "text": "This index is in word-by-word order with hyphens within index headings are ignored in the alphabetization. For example, sweating is alphabetized after sweat test, not after structural matrices or C-family is after CetZs, and not at the start of the C section. Prefixes and terms in parentheses are excluded from the initial alphabetization.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Index"
        },
        {
            "text": "Where index subentries and sub-subentries pertaining to a subject have the same page number, they have been listed to indicate the comprehensiveness of the text. adenoid cystic carcinoma (ACC) accessibility, of protein 1:69 accessory proteins 2:478-481, 2:588 accountability 1:68-69 ACD protein homolog see adrenocortical dysplasia protein homolog (ACD protein homolog) ACE see angiotensin I converting enzyme (ACE); angiotensin-converting enzyme (ACE) AceCS2 see acetyl co-enzyme A synthetase 2 (AceCS2) acentrosomal nucleation 2:544 acentrosomal spindle assembly 2:638 acetal protecting groups 1:43-44 1-aryl-4-alkoxypiperidin-4-yl groups 1:43-44 2-cyanoethyloxymethyl group 1:44-45 triisopropylsilyloxymethyl group 1:44 acetyl coenzyme A 1:14 acetyl co-enzyme A synthetase 2 (AceCS2) 3:781 acetylated tubulin 3:233 acetylation 3:507 acetylcholinesterase (AChE) 1:248 acetyl-CoA/CoA ratio 1:288, 1:292-293, 1:296 for ATP production and/or lipid synthesis 1:294 in fatty acid oxidation and ketogenesis 1:296 in regulation of fatty acid synthesis 1:293F, 1:294 in regulation of glycogen synthesis 1:291 in regulation of pyruvate dehydrogenase complex 1:293-294 acetyl-CoA carboxylase (ACC) 1:290, 1:293F, 1:294 acetyl-Ser-Asp-Lys-Pro (AcSDKP) 1:748 ACFD see acrocapitofemoral dysplasia (ACFD) ACG for activated Cdc42-associated GEF see DOCK11 achaete-scute homologue 2 (Ascl-2) 3:542 AChE see acetylcholinesterase (AChE) Acholeplasma laidlawii (A. laidlawii) 1:164 acid hydrolase 1:769, 1:770, 1:772, 1:773, 1:777-778, 1:780-781, 1:783-784 acid maltase 1:764, 1:767, 1:768-769, 1:770, 1:771-772 recombinant 1:767 acid sphingomyelinase (ASMase) 1:613, 2:225-226 acid-base catalysis 1:16F, 1:18 acid-base reactions 1:10 acidification 2:426 AcMNPV see Autographa californica (alfalfa looper) multiple nuclear polyhedrosis virus (AcMNPV) ACP see acyl carrier protein (ACP) Acp2 1:778 Acp5 1:776, 1:776-777, 1:778 acquired immune system see adaptive immune system acquired immunity 3:580 acquired immunodeficiency syndrome (AIDS) 1:739, 2:828, 3:585 see also human immunodeficiency virus (HIV) acrocapitofemoral dysplasia (ACFD) 3:81 ACs see anterograde carriers (ACs) AcSDKP see acetyl-Ser-Asp-Lys-Pro (AcSDKP) ActD see actino-mycin D (ActD) ACTH see adrenocorticotropic hormone (ACTH) actin 2:4, 2:26F, 2:27, 2:28F, 2:367, 2:436, 2:438, 2:548-549, 2:761-762, 2:795, 3:199, 3 :367 see also intermediate filaments (IFs); microtubules (MTs) actin-based motility 2:560-561 atomic structure of monomeric actin 2:550F depolymerization 2:787-788 and membrane rearrangement 2:787 polymerization 2:726, 2:754-755 phagocytosis signaling to 2:752-753 polymerization-driven protrusion 2:683-686 regulators in adhesion structures 2:561-564 reorganization 2:726 role in gene expression regulation 2:564-565 self-assembly bulk solution studies 2:552-553 single filament assembly dynamics 2:553-554 treadmilling regulation by ADF and capping proteins 2:553F structural and mechanical properties 2:549-552 actin assembly dynamics 2:548-568",
            "cite_spans": [
                {
                    "start": 2363,
                    "end": 2371,
                    "text": "3:199, 3",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Index"
        },
        {
            "text": "actin-based molecular motors 2:564 bacterial actin ancestors 2:565 cellular examples of motile processes 2:562F DRFs and non-DRFs 2:558T integrated protein modules in reconstituted actin-based motility 2:560-561 regulation by associated proteins 2:554-557 barbed end-capping proteins 2:557 barbed-end trackers 2:557 G-actin binding proteins 2:554-557 pointed end binding proteins 2:557-558 proteins binding to sides of actin filaments 2:558-559 WH2 domain 2:559-560 regulators 2:555-556T site-directed branching of actin filaments 2:560 actin barbed face 2:549 actin cytoskeleton 1:202, 2:581-584, 2:600-601, 2:602, 2:687-688, 3 see Runt-related transcription factor-1 (RUNX1) acute phase reactant 1:790 acute phase response (APR) 2:534 acute promyelocytic leukemia 3:811 acyl carrier protein (ACP) 1:161 acyl coenzyme A binding protein (AcbA/Acb1) 2:520 acyl-coenzyme A:cholesterol acyltransferase (ACAT) 1:173-174 acyltransferases 1:204F, 1:205 AD see activation domain (AD); Alzheimer's disease (AD); anauxetic dysplasia (AD) ADAM see a disintegrin and metalloproteinase (ADAM) Adams-Oliver syndrome (AOS) 3:109-110 ADAMTS proteases see a disintegrin-like and metalloprotease domain with thrombospondin proteases (ADAMTS proteases) adaptation 4:154 adaptins see Assembly polypeptides (APs) adaptive immune response 3:695 initiation and regulation 3:617-618 adaptive immune system 3:1, 3:592-593, 3 Aliphatic acid-type histone deacetylase inhibitors 1:62 ALK see anaplastic lymphoma kinase (ALK) alkaline pancreatic fluid 1:257-259, 1:259F alkaline phosphatase (ALP) 3:797 alkyne-labeled coenzyme Q analogues 1:128 allelic exclusion 3:553F, 3:554-555 allograft rejection 3:642 allosteric control 1:288 allosteric effectors 1:249-250 allosteric enzymes 1:9, 4:31, 4:32 allosteric site 1:744 allotransplantation 3:808 all-trans retinoic acid (ATRA) 3:811 ALP see alkaline phosphatase (ALP) alpha granules 1:715, 2:235, 2:235-236 alpha-1-antitrypsin deficiency (a1-ATD) 1:3-4, 1:789 cellular mechanisms of liver disease 1:792-794 of lung disease 1:794 cellular responses to misfolding of mutant ATZ 1:794-796 mechanism of deficiency in classical form of 1:791-792 physiology and function of AT 1:790-791 therapies for ATD liver disease 1:796-797 lung disease 1:797 a1 protease inhibitor (a1PI) 1:710 a1-adrenoceptor (a1-AR) 3:51 a1-antitrypsin (AT) 1:789 physiology and function of 1:790-791 a1-antitrypsin Z (ATZ) 1:789 cellular responses to misfolding of mutant 1:794-796 a1-AR see a1-adrenoceptor (a1-AR) a1-ATD see alpha-1-antitrypsin deficiency (a1-ATD) a1PI see a1 protease inhibitor (a1PI) a2-antiplasmin (a2-AP) 1:717 a2-macroglobulin 1:626-627 a-amino acid structures 1:15T a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 2:219-220, 2:294, 2:453, 2:499, 3:235 a-amylase 1:125 a/b hydrolases 1:91-92 a-families 2:627 a-hemolysin 4:162 a-ketoacid dehydrogenase 1:14 a-mannosidase 1:539-540T, 1:541F, 1:543, 1:779-780, 1:783 a-mannosidosis 1:783 a-subunit of flavocytochrome b 558 see p22phox a-subunit of IL-3 receptor (IL-3Ra) 3:24 a-synuclein 1:206F, 1:771-772, 1:773 alpha-tubulin (A-lattice) 2:539, 2:539-540 Alps see actin-like proteins (Alps) ALPS1B see autoimmune lymphoproliferative syndrome (ALPS1B) ALRs see AIM2-like receptors (ALRs) ALS see amyotrophic lateral sclerosis (ALS) ALT see alternative lengthening of telomeres (ALT) alternative end-joining (aEJ) see microhomology-mediated end-joining pathway (MMEJ) alternative lengthening of telomeres (ALT) identification, structure, and mechanism 1:662 inhibitors 1:663 knockout mice 1:662-663 other substrates 1:663 prospects for therapeutics 1:663-664 g-secretase identification and mechanism 1:664 inhibitors and modulators 1:665 other substrates 1:664-665 prospects for therapeutics 1:666 structure elucidation 1:665-666 presentation and pathology 1:661 AMAMTS proteases 1:754-755 amaurotic familial idiocy 1:767 ambisense RNA viruses 1:517, 1:518T, 1:521 AMBRA1 see activating molecule in BECLIN1-regulated autophagy (AMBRA1) AMD see age-related macular degeneration (AMD) American Oil Chemistry Society (AOCS) 1:153, 1:180 AMH see anti-M\u00fc llerian hormone (AMH) amidation 1:86-87 amiloride 2:762 amine-containing phospholipids synthesis 1:162 in bacteria 1:162 in eukaryotes 1:164-166, 1:165F aminopeptidases (AP) AP cortical polarity see anterior-posterior cortical polarity (AP cortical polarity) AP endonuclease 1 (APE1) 1:442-443 AP sites see apurinic sites (AP sites) AP1 see activator protein 1 (AP1) AP180 N-terminal homology domain (ANTH domain) 2:455, 2:507-508 APAF-1 see adaptor protein apoptotic protease activating factor 1 (APAF-1) APAF1 see apoptotic peptidase activating factor 1 (APAF1) Apaf-1 see apoptotic protease-activating factor (Apaf-1) Apaf1 see apoptotic protease activating factor 1 (Apaf1) APC see adenomatous polyposis coli (APC); antigen presenting cells (APCs) APC/C see anaphase-promoting complex/ cyclosome (APC/C) APCI see atmospheric pressure chemical ionization (APCI) APE1 see AP endonuclease 1 (APE1) Aph-1 1:665 API see active pharmaceutical ingredient (API) apical early endosomes ( 2:530 apoptosis-associated speck-like protein containing caspase recruitment domain (ASC) 2:523-524 apoptosis-inducing factor, mitochondrionassociated 1 (AIFM1) 3:342 apoptosome 1:708, 3:69-70, 3:328, 3:328F, 3:329, 3:330, 3:345, 3:368-369, 3:368-370, 3:369-370, 3 :369F apoptotic bodies 3:327, 3:328, 3:328F apoptotic caspases 3:329, 3:364, 3:364-366, 3 :369-370 apoptotic peptidase activating factor 1 (APAF1) 3:343 apoptotic protease activating factor 1 (Apaf1) 1:615, 3:69-70, 3:328 apoptotic/apoptosis 2:766, 2:773, 3:67, 3:379, 3:399, 3:402, 3:440, 3 :582 see also B-cell lymphoma 2 proteins (Bcl-2 proteins) bodies 2:304 cell death ligand 3:393-394 cells clearance by MZ macrophages 3:763 differentiation program 2:773 intrinsic and extrinsic apoptotic pathways (ARTS) 1-aryl-4-alkoxypiperidin-4-yl groups 1:43-44, 1:44F Arylsulfatase A 1:774, 1:784-785, 1:785 ASC see apoptosis-associated speck-like protein containing caspase recruitment domain (ASC) Ascaris pepsin inhibitor 1:684 ASCE see additional strand catalytic E (ASCE) Ascl-2 see achaete-scute homologue 2 (Ascl-2) ascorbate 1:87 ASCs see antibody-secreting cells (ASCs) ASFV see African swine fever virus (ASFV) ASGR see Ashwell-Morrell receptor (ASGR) ASMase see acid sphingomyelinase (ASMase) Ashwell-Morrell receptor (ASGR) 2:344 ASK1 see apoptosis signal regulating-kinase 1 (ASK1) ASL see airway surface liquid (ASL) Asn-Pro-x-Tyr motifs (NPxY motifs) 2:480 asparaginyl endopeptidase (AEP) 3:590 aspartic acid tRNA (tRNA Asp ) 1:318 aspartic peptidases 1:681 aspartic protease 1:739 cathepsin D 1:753 aspirin 1:133F assembly chaperone 1:589F, 1:590-591 assembly polypeptides (APs) 2:450 asthma 3:26 astral microtubules 3:480 astrocyte 2:569 reactive 3:800 asymmetric cell division 2:656 AT see a1-antitrypsin (AT); antithrombin III (AT) AT 1 A R see angiotensin II Type 1 Areceptor (AT 1 A R) ataxia telangiectasia mutated protein (ATM protein) 3:103, 3:473, 3:781 ataxia-telangiectasia mutated kinase (ATM kinase) 3:504-505, 3:816 atazanavir 1:743 ATF4 see activating transcription factor-4 (ATF4) ATF6 see activating transcription factor 6 (ATF6) ATG see autophagy-related genes (ATG) Atg7 see autophagy-related protein 7 (Atg7) Atg8 see LC3/GABARAP/GATE16 (Atg8) ATG8/LC3 1:584T, 3:591 and ATG12 1:588 ATG12 1:584T, 3 Dictyostelium diskoideum, whole cell tomography of 2:26F Diego (dg) 2:746-747 diethylaminoethyl (DEAE) 1:71, 3:60 diethylpyrocarbonate 1:27-28, 1:30F differential analysis 4:202 differential centrifugation 1:66 differential in gel electrophoresis (DIGE) 1:571, 1:571-572, 1:571F differential precipitation 1:70 differential-adhesion driven cell sorting 4:126-127 differentially expressed genes (DE genes) 4 see also genetically encoded fluorescent probes calcium-dependent fluorescence using GCaMP 2:53F FRAP 2:52F imaging with multiple fluorescent proteins 2:52F 2-photon microscopy 2:55, 2:55F as probes for function 2:52-54 single-particle tracking with 2:57F super-resolution imaging 2:58F fluoxetine 1:248 flux connectivity theorem 4:28-29 flux control coefficient 4:27-28 FMDV see foot and mouth disease virus 3:317, 3:434, 4:160, 4:191-192, 4:211-212, 4:213, 4 PRLYL residues see Pro-Arg-Leu-Tyr-Leu residues (PRLYL residues) PRM see parallel reaction monitoring (PRM) pRNA see promoter RNA (pRNA) PRNP see prion gene (PRNP) proangiogenic MMP-9 delivering neutrophils 3:754 pro-ANP see pro-atrial natriuretic peptide (pro-ANP) pro-apoptotic machinery 3:328-330, 3 :330 B-cell lymphoma-2 (Bcl-2) family 3:330 caspases 3:329-330 lipids 3:330 Pro-Arg-Leu-Tyr-Leu residues (PRLYL residues) 2:475-476 pro-atrial natriuretic peptide (pro-ANP) 1:656-657 probabilistic methods 4:258 procaspase zymogens 3:364, 3:366 procentriole 2:649, 2:651, 2:651-653 processive, defined 1:396 processive assembly of filaments 2:548 processive tracking 2:685-686 processivity 2:597 factor 1:447-448 procollagen molecules 2:699 processing 1:634 17-producing helper T cell (Th17) 3:721-722 profilin 2:556-557, 2:557, 2:685 progenitors 3:6, 3:6-7 progerin 2:313 progesterone 1:178-179 programmed cell death (PCD) 3:2, 3:3, 3:4, 3:67, 3:327, 3:342, 3:364, 4 :95 PD-1 3:545 PDCD4 3:245 programmed death receptor 1:145 progressive-lowering of temperature protocol (PLT protocol) 2:34 pro-hepatocyte growth factor (pro-HGF) 1:655 pro-HGF see pro-hepatocyte growth factor (pro-HGF) prohibitins (PHB) 2:283 prohormone convertase 1/3 (PCSK1) 1:555, 1:557, 1:557, 1:564T calcium dependence 1:558 cleavage of prodomain 1:557-558 dibasic site 1:558F general properties of 1:557 PC1/3 maturation in the regulated secretory pathway 1:557-558 physiological significance of 1:558-559 prohormone convertase 2 (PCSK2) 1:559-560, 1:564T calcium dependence 1:560 general properties of 1:560 physiological significance of PC2 1:104 relevance to cell biology 1:105 spatial light modulator (SLM) 2:78, 2:89 'spatial' models 4:17 spatial proteomics 3:265 spatial relocation 3:720-721 spatial restriction 2:505-507 spatial sensing 4:6 SPB see spindle pole body (SPB) SPC see signal peptidase complex (SPC); subtilisin-like pro-protein convertase (SPC) SPD see serine protease domains (SPD) specific granules (SG) 2:770 see also secondary granules specific ICAM-3-grabbingnonintegrin (SIGN) 3:746 specific N-terminal residue 1:326 specific pathogen-free mice (SPF mice) 2:800-801 specimen preparation for SEM 2:17 spectrin 3:231 sperm formation 2:248 spermiogenesis 2:248 SPF mice see also see specific pathogen-free mice (SPF mice) S-phase kinase associated protein 1 (SKP1) 3:439 S-phase kinase associated protein 2 (SKP2) 3:439 spheroid 3:808, 4:74-75 spherules 2:819-820 formation 2:820F sphinganines 1:183-184 sphingolipid activator proteins (SAP) 1:774 (SRCR) SREBP see sterol response element binding protein (SREBP) SREBP cleavage activating protein (SCAP) 1:175-176, 1:176F SREs see Smaug recognition elements (SREs) srGAP family see Slit-Robo Rho GTPase activating protein family (srGAP family) SrGAP3 2:493-494 SRM see selected reaction monitoring (SRM) SRP see signal recognition particle (SRP) SRP pathway see signal recognition particle pathway (SRP pathway) SRP receptor (SR) 1:535, 1:537-538, 2:447 SRP9 1:537T SRP14 1:537T SRP19 1:537T SRP54 1:537, 1:537T SRP68 1:537T SRP72 1:537T SRs see Scavenger receptors (SRs) SRSF1 1:508 SRSF2 1:508 SRY see Sex-determining region Y (SRY) SRY-box 2 (Sox2 ",
            "cite_spans": [
                {
                    "start": 627,
                    "end": 628,
                    "text": "3",
                    "ref_id": null
                },
                {
                    "start": 1399,
                    "end": 1400,
                    "text": "3",
                    "ref_id": null
                },
                {
                    "start": 5292,
                    "end": 5371,
                    "text": "3:69-70, 3:328, 3:328F, 3:329, 3:330, 3:345, 3:368-369, 3:368-370, 3:369-370, 3",
                    "ref_id": null
                },
                {
                    "start": 5435,
                    "end": 5461,
                    "text": "3:329, 3:364, 3:364-366, 3",
                    "ref_id": null
                },
                {
                    "start": 5628,
                    "end": 5663,
                    "text": "3:67, 3:379, 3:399, 3:402, 3:440, 3",
                    "ref_id": null
                },
                {
                    "start": 7400,
                    "end": 7401,
                    "text": "3",
                    "ref_id": null
                },
                {
                    "start": 7796,
                    "end": 7806,
                    "text": "(DE genes)",
                    "ref_id": null
                },
                {
                    "start": 8218,
                    "end": 8269,
                    "text": "3:317, 3:434, 4:160, 4:191-192, 4:211-212, 4:213, 4",
                    "ref_id": null
                },
                {
                    "start": 8571,
                    "end": 8572,
                    "text": "3",
                    "ref_id": null
                },
                {
                    "start": 9201,
                    "end": 9239,
                    "text": "3:3, 3:4, 3:67, 3:327, 3:342, 3:364, 4",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Index"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "SMA see spinal muscular atrophy (SMA) SMAC see second mitochondria-derived activator of caspase (SMAC) SMAD anchor for receptor activation (SARA) 2:212",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "759--760",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "1:355, 1:358, 4:267 small intestine in proteolysis 1:733-735 small leucine-rich proteoglycans (SLRPs) 1:273-274, 2:700 small molecule 3:385 small nuclear ribonucleoproteins (snRNP) 1:495, 1:496, 1:497",
            "authors": [],
            "year": null,
            "venue": "Ras 2:759 small hairpin RNA (shRNA) library 3:674 small interfering RNA (siRNA) 1:27",
            "volume": "1",
            "issn": "",
            "pages": "256--257",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "162 -derived RNA (sdRNA) 4:160, 4:162 small ribosomal proteins 3:3 small RNAs and cancer 1:364 miRNAs 1:364 biogenesis 1:364-365 and cancer 1:366 discovery 1:364 etiology 1:366 IsomiRs 1:368-369 nomenclature 1:365-366 prognosis predicting and therapy response 1:366-367 role in carcinogenesis 1:367 as a target for therapy",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "small subunit of ribosome (RPS) 3:281 small synaptic vesicles 2:380 small ubiquitin-like modifier protein (SUMO protein) 2:287-288, 2:574 small vessels vasculitis (SVV) 3:755 small-angle X-ray scattering (SAXS) 1:94, 3:704 small",
            "authors": [],
            "year": null,
            "venue": "Small SubUnit (SSU)",
            "volume": "3",
            "issn": "",
            "pages": "67--68",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Smaug recognition elements (SREs) 3:323 SMB see somatomedin-B (SMB)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "spindle length control 2:641 spindle microtubules 3:494, 3:495F spindle midzone 2:639 spindle pole body (SPB) 2:315, 2:649 spinesin see TMPRSS5 Spiroplasma melliferum 2:27, 2:27F spleen, macrophage subsets in 3:759, 3:760F apoptotic cells clearance by MZ macrophages 3:763 metallophilic macrophages",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "762--763",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "spleen tyrosine kinase (syk) 3:528, 3:751 splenic MZ 3:759-761 macrophage populations in 3:761F splice sites 1:503",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "1:499F, 1:501, 1:503, 1:504F, 1:505F, 1:506 splice variants of VEGFR1 (sVEGFR1) 4:106 splice variants of VEGFR2 (sVEGFR2) 4:106 spliceosome 1:503, 1:503-505, 1:506, 1:507, 1:509 active site of 1:499-500, 1:499F alternative splicing and creation of multiple products from single gene 1:500-501 assembly on introns 1:498-499 chemistry of splicing and architecture of intron 1:495-496 comparison of snRNP components for Saccharomyces cerevisiae and Homo sapiens",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "DExD/H box proteins are essential cofactors of the 1:500 diseases of 1:507-508 and pre-mRNA splicing 1:495-502 retinitis pigmentosa and neurodegeneration 1:508 snRNAs and proteins 1:496-498 splicing factor mutations and cancer 1:508 splicing mutations in growth and development",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "508--509",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "1:498F, 1:501 splicing regulatory (SR) proteins 1:497-498 split PH domain (spPH) 3:153 s-pol incident light 2:63-64 spondylocostal dysostosis (SCDO) 3:109-110 spondyloenchondrodysplasia 1:776-777 spondyloepi-physial dysplasia tarda (SEDT) 2:335 sporadic CJD (sCJD) 2:840 sporadic fatal insomnia (sFI) 2:840-841 spPH see split PH domain (spPH) SPR see surface plasmon resonance (SPR) SPRI measurements see surface plasmon resonance imaging (SPRI) measurements spring forces 4:120 sprout fusion and flow",
            "authors": [],
            "year": null,
            "venue": "ECM proteolysis 4:110 endothelial junction structure and destabilization 4:111F migration and proliferation 4:111-112 pericytes dissociation 4:111 sprout fusion and flow",
            "volume": "1",
            "issn": "",
            "pages": "477--478",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "sptPALM see single-particle tracking PALM (sptPALM) Spumaretroviruses 1:523 sputter coating 2:17 SQ see sulfoquinovose (SQ)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "SQ/TQ rich domain see Ser-Gln/Thr-Gln rich domain (SQ/TQ rich domain) squamous cell carcinoma cells (SCC) 2:723, 3:110 SR see sarcoplasmic reticulum (SR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "SR proteins see Serine-Arginine rich (SR) proteins; splicing regulatory (SR) proteins SR-A see scavenger receptor A (SR-A) Src family 3:439",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "442--444",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Src family of tyrosine kinases (SFKs) 3:696 src homology (SH) 2:597",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "113--114",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "function 3:118 SHP-2 phosphatase 3:119 SOS protein 3:119 SRC Kinase modulation of activity 3:119 regulating pathway activation 3:118F Src homology 3 (SH3) 1:92, 3:703 domains 3:113-114, 3:153 atypical binding motifs 3:115 function 3:118-119 model for bidirectional binding of proline type 2 helices by 3:114F specificity and promiscuity",
            "authors": [],
            "year": null,
            "venue": "132 domains 3:115 specificity and promiscuity 3:117-118 structure 3:116, 3:116F target recognition motifs",
            "volume": "2",
            "issn": "",
            "pages": "112--113",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "SRC Kinase modulation of activity 3:119 Src-family kinases (SFK) 2:759 SRCR see scavenger receptor cysteine rich",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "proteolysis of versican 1:635-636 ADAMTS1 and female infertility 1:636 A site 3:310 A 3 cluster 3:289 AAA protein see ATPase associated with various cellular activities protein (AAA protein) AAA \u00fe protein 1:396, 1:401-403, 1:403 AAA \u00fe ring domains 2:621 AAA-adenosine triphosphatase (ATPases) 3:299 AA-tRNA see aminoacyl-tRNA (AA-tRNA) AAV see adeno-associated viral (AAV) AB 5 toxins 2:434, 2:438 abasic site incision 1:446-447 ABBA see actin-bundling protein with BAIAP2 homology (ABBA) ABC see activated B-cell (ABC); aggressive activated B cell (ABC) ABCD4 gene 1:775 ABCE1 1:527, 1:530F, 1:531, 1:532 ABCP see apical-basal cell polarity (ABCP) Ab peptide see amyloid b-peptide (Ab peptide) ABFs see antibacterial factors (ABFs) ABM see actin-based motility (ABM); agent-based modeling (ABM) abnormal calpain activation 1:675 abscission 3:497 checkpoint 3:501 ESCRT proteins 3:499 membrane fusion 3:498-499 midbody remnant 3:499 vesicle trafficking 3:497-498 abscission checkpoint 2:470 abscission/NoCut checkpoint regulator (ANCHR) 2:470, 3:475 absent in melanoma 2 (AIM2) 3:710 absolute reaction rate theory 1:18 absorption, nutrient 1:732, 1:734, 1:736 ACAT see acyl-coenzyme A:cholesterol acyltransferase (ACAT) AcbA/Acb1 see acyl coenzyme A binding protein (AcbA/Acb1) ACC see acetyl-CoA carboxylase (ACC);",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "state profile 4:16F Open Model 4:17, 4:18F 3D lamellipodium 4:20 treadmilling process 4:15F experimental investigation 4:10 mechano-chemical control of cell motility and shape 4:10 actin filament treatment 4:11 biophysical mechanisms 4:14 Brownian ratchet formalism 4:10, 4:10 fish keratocyte cell phase microscopy image 4:12F G-actin transport 4:13 locomotion mechanism 4:13F model types and evolution 4:11F network swelling model 4:12 actin elongation 2:691 actin filaments 2:551-552, 2:677-679, 2:725, 2:752 see also intermediate filaments (IFs); microtubules (MTs) nucleation of 2:554 organization 2:683F, 2:684F in filopodium 2:686F in lamellipodium 2:689F proteins binding to sides of 2:558-559 activation, Class I and Class II 1:476-477 activation, Gibbs free energy of 1:8 activation domain (AD) 3:704 activation induced cell death (AICD) 3:567 activation induced TNF-receptor (AITR) 3:62 activation-induced cytidine deaminase (AID) 3:552 activation-induced deaminase (AID) 3:543-544 activator protein, deficiency of 1:774 galactosialidosis 1:774 sphingolipid activator proteins (SAP) 3:39, 3:44 activity-based probes 1:131, 1:131F actomyosin cytoskeleton 2:603, 2:604 actomyosin-driven contractility 2:604-605 acute kidney injury (AKI) 1:694 acute myelogenous leukemia (AML)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "see actin depolymerizing factor (ADF) ADF homology module (ADFH) 2:559 adherens junctions (AJs) 2:742, 2:744-745, 3:182 actin dynamics at 3:187 in disease 3:188-189 diversity 3:183-184 adhesion adhesive strengthening 2:706 frequency 3:661 maturation 2:720-721 mechanisms for adhesion and diapedesis across endothelia cytoskeletal remodeling 3:637 molecular basis for adhesion and diapedesis 3:636-637 -mediated signaling 2:713 adhesome 2:724 adipocytes 2:274, 2:276 LDs 2:274 ADP see adenosine diphosphate (ADP) ADPKD see autosomal dominant polycystic kidney disease (ADPKD) ADP-ribosylation factor (Arf) dysplasia protein homolog (ACD protein homolog) 1:427 adrenocorticotropic hormone (ACTH) 2:376-377 adrenoleukodystrophy 2:269 adsorption chromatography 1:72 dye-ligand chromatography 1:72 HILIC 1:72 inorganic adsorbent chromatography 1:72 adult cell fate, plasticity of 3:791 adult central nervous system stem cell niche CNS stem cell niches 3:800 interactions between niche cells and tissue progenitors-soluble factors 3:799 SGZ interactions 3:800 SGZ neural stem cell niche 3:799 stem cell 3:800 SVZ interactions 3:799-800 tissue with functional stem cells 3:797-798 V-SVZ neural stem cell niche 3:798-799 adult stem cell niche adult central nervous system stem cell niche 3:797-798 cell-matrix contacts 3:802 heart-evidence for cardiac stem cell niche 3:800-801 juxtacrine signaling 3:802-803 paracrine signaling 3:802-803 skeletal muscle 3:796-797 skin hair follicle 3:794-795 ventricular-subventricular zone neural 3:798F adult stem cells, aging in HSC 3:780-782 MSCs 3:780 muscle stem cells 3:778 adult-born cells 4:137 adulthood, changes in gut microbiome 2:802 advanced glycation end-products (AGEs) 3:734-735 AEE see apical early endosomes (AEE) AEP see asparaginyl endopeptidase (AEP) aequorin 1:125 affinity chromatography 1:72 affinity tag chromatography 1:73 immunoaffinity chromatography 1:72 lectin affinity chromatography 1:72 metabolite affinity chromatography 1:72-73 affinity labeling 1:130-131 affinity purification mass spectrometry (AP-MS) 4:170-171, 4:190, 4:247 affinity tag chromatography 1:73 African swine fever virus (ASFV) 2:824 Ag see antigen (Ag) AG see azurophilic granules (AG) AGC catalytic triad 1:497, 1:499F agent-based modeling (ABM) 4:80, 4:80-81 age-related macular degeneration (AMD) 1:707, 2:111-112 AGEs see advanced glycation end-products (AGEs) aggrecanases in osteoarthritis 1:635 aggregation ICS 2:103 PCH 2:103 aggresomes, NCLDV using 2:824-825 and perinuclear sites 2:824F aggressive activated B cell (ABC) 4:252-253 aging 1:719-720, 3:438, 3:776 in adult stem cells cell regenerative potential declines with 3:777F aging factors 1:203 AGO see Argonaute (AGO) Ago2 P-body protein 1:350 agouti-related protein (Agrp) 2:289 agrin 2:697 Agrp see agouti-related protein (Agrp) AGS see Aicardi-Gouti\u00e8res syndrome (AGS) Aicardi-Gouti\u00e8res syndrome (AGS) 3:720 AICD see activation induced cell death (AICD); APP intracellular domain (AICD) Aichivirus (AV) 3:310-312 AID see activation-induced cytidine deaminase (AID); activation-induced deaminase (AID) AIDS see acquired immunodeficiency syndrome (AIDS) AIFM1 see apoptosis-inducing factor, mitochondrion-associated 1 (AIFM1) AIM2 see absent in melanoma 2 (AIM2) AIM2-like receptors (ALRs) 3:719-720 AIR see autoinhibitory region (AIR) AIRE see autoimmune regulator (AIRE); auto-immune regulator transcription factor (AIRE) airway surface liquid (ASL) 1:252, 1:255-256 AITR see activation induced TNF-receptor (AITR) AJs see adherens junctions (AJs) AK see adenylate kinase (AK) AKAP see A-kinase anchoring protein (AKAP) AKI see acute kidney injury (AKI) A-kinase anchoring protein (AKAP) 2:661-663 Akt 3:129-130, 3:815 AKT1 mutation 3:419 inactivation 3:132-133 isoform domain structure 3:129F alanine aminopeptidase 1:734-735 alanine scanning mutagenesis 1:122-123, 1:123, 1:123-124 alanyl-tRNA synthetase 1:22-23 A-lattice see alpha-tubulin (A-lattice) Ala-Val-Pro-Ile (AVPI) 3:395 albonoursin 1:326-327 albumin 2:382 ALCL see Ana-plastic large-cell lymphoma (ALCL) aldehyde dehydrogenase (ALDH) 3:595 aldosterone 1:178-179 Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) 4:258-259 algorithms 4:211-212, 4:214",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "see adenosine monophosphate (AMP) AMPA see a-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) amphipathic N-terminal helix domains (N-BAR domains) 2:491, 2:498 amphiphysin I 2:498 amphiregulin 1:641 amphisome 2:246 AMPK see adenosine monophosphate activated kinase (AMPK) AMPs see antimicrobial proteins and peptides (AMPs) AMPylation see Rab1 by adenylylation (AMPylation) AMRF see action myoclonus-renal failure syndrome (AMRF) AMT see amoeboid-mesenchymal transition (AMT) amyloid 1:113 amyloid plaques 1:241, 1:661 amyloid precursor protein (APP) genetic basis of ALS 1:116 Anabaena peroxidase 1:125 Anakinra 3:29 anaphase 3:481 CPC during 3:475 sensing mechanism 4:109F hypoxic induction 4:109-110 intussusceptive angiogenesis 4:114 meprins in 1:695 primary factors controlling 4:104 angiogenic growth factors 4:104 capillary growth factor ligand, receptor, and co-receptor domain structures 4:105F FGF-VEGF-Ang-PDGF networking 4:108-109 vascular remodeling factors 4:107 sprouting angiogenesis 4:110 vascular evolution 4:102 vasculogenesis and 4:127-128 venous vessels 4:114-115 angiogenic growth factors 4see angiopoietin-1 (Angpt1) aNHEJ see alternative NHEJ (aNHEJ) anillin 3:495-496 animal viruses 2:809F endocytic entry pathways for 2:813F stepwise host cell entry 2:811F anion exchange 1:66 anionic lipid 1:194 anisotropy 2:64 ankyrin repeats (ANK) 3:107 anoikis 3:227, 3:335see atrial natriuretic peptide (ANP) ANPCR see ANP clearance receptor (ANPCR) ANT see adenine nucleotide translocase (ANT) antagonists 3:395-396 anterior-posterior cortical polarity (AP cortical polarity) 2:741-742 anterograde carriers (ACs) 2:175 anterograde IFT motor 2:665-666 anterograde transport 2:168, 2:354, 3:236 ANTH domain see AP180 N-terminal homology domain (ANTH domain) anti-apoptotic proteins 3:331, 3:370, 3:607 anti-apoptosis proteins of viral origin 3:332 Bcl-2 family 3:331-332 IAPs 3:330-331 antibacterial factors (ABFs) 2:847 antibiotics 2:803-804 synthesis by fungi 2:255 antibody(ies) 1:138-139, 1:141-142 angiogenesis and vascular blockade/ transport 1:145 antibody-based methods 4:178-179 engineering multiple specificity in antibody fragments bifunctional antibodies 1:143 bispecific antibodies 1:143 fragments design 1:142-143 high-value clinical applications 1:145 pathogen neutralization, antiviral therapy, and vaccines 1:145 T-cell targeting and immune checkpoint inhibitors 1:145 image-guided surgery 1:145-146 for in vivo applications 1:142 intact antibodies vs. fragments 1:143 libraries 1:143-144 bacteriophage display 1:144 cell-surface libraries 1:144 maturation 1:144-145 transgenic mice 1:144 production, stability, and expression levels 1:145 antibody-dependent cellular cytotoxicity (ADCC) 2:835 antibody-drug conjugates (ADCs) 3:399, 3:401 anti-DNP antibodies 1:18-19 antigen (Ag) 3:519, 3:632, 3:759-760 capture 3:746 presentation 1:764, 2:177, 3:746 endothelial cells properties 3:639-640 antigen-specific immunity, endothelial function in 3:639 antigen recognition and responses 3:642 EC Ag presentation emerging and putative roles 3:640-641 endothelial antigen presentation in pathology 3:641-642 endothelial cells antigen presenting properties 3:639-640 model for ILPs function in Ag recognition and response 3:643F antimicrobial proteins and peptides (AMPs) 2:771 anti-M\u00fc llerian hormone (AMH) 3:37 anti-neutrophil cytoplasmic antibodies (ANCA) 3:755 anti-recombination 1:464 antithrombin III (AT) 1:710 antitumor 1:753, 1:755, 1:757 antiviral therapy 1:145 AOCS see American Oil Chemistry Society (AOCS) AOS see Adams-Oliver syndrome (AOS) AP see adaptor protein (AP);",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "AEE) 2:192-193 apical membrane 1:252, 1:257 apical recycling endosomes (ARE) 2:745-746 apical-basal cell polarity (ABCP) 3:99 apical-basal polarity 2:742 proteins interplay organizing 2:745 aPKC see atypical protein kinase C (aPKC) AP-MALDI see atmospheric pressure matrixassisted laser desorption/ionization (AP-MALDI) AP-MS see affinity purification mass spectrometry (AP-MS) ApoB see apolipoprotein B (ApoB) APOBEC3G restriction factor 2:836 ApoE see apolipoprotein E (ApoE) apoE receptor 2 (apoER2) 2:419-420 apolipoprotein B (ApoB) 1:176 apolipoprotein E (ApoE)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "by XIAP 3:391 APP see amyloid precursor protein (APP); amyloid-b precursor protein (APP); amyloid b-protein precursor (APP) APP intracellular domain (AICD) 1:661-662 APPL see adaptor protein containing PH domain PTB-domain and leucine zipper motif (APPL) APR see acute phase response (APR) APs see Assembly polypeptides (APs) aptamer 1:375, 1:377, 1:382, 3:668-669F, 3:669 in vitro selection of 1:375 and riboswitches 1:375-377 apurinic sites (AP sites) 3:462 AQUA peptides 4:169 Arabidopsis thaliana regulation of root growth by auxin in 4:128-131 arachidonic acid 1:194-195, 1:195 ARACNe see Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) Arch see archaerhodopsin-3 (Arch) archaea 1:155, 1:160-161, 2:588, 2:800 cytokinesis 2:588-590 ESCRT-based cell division 2:590F, 2:592 transcription and regulation in 1:477-478 Z-ring placement at mid-cell 2:590-592 structure and constriction mechanism 2:588-590 archaerhodopsin-3 (Arch) 2:151 archaerhodopsins (Archs) 2:148-149 Archs see archaerhodopsins (Archs) ARE see apical recycling endosomes (ARE); AU-rich element (ARE) AREs see adenylate/uridylate-rich elements (AREs) ARF see adenosine diphosphate ribosylation factor (ARF) Arf see ADP-ribosylation factor (Arf) ARF protein see alternative reading frame protein (ARF protein) ARF tumor suppressor protein 3:5 ArfGTPase activating domain (ArfGAP) see autosomal recessive hypercholesterolemia (ARH) ARID see autosomal recessive intellectual disability (ARID) Arl families see Arf-like families (Arl families) Arl-13/ARL13b compartment 2:667 arLCA see autosomal Leber congenital amaurosis (arLCA) AROS see active regulator of SIRT1 (AROS) Arp2/3 complex see actin-related protein 2/3 complex (Arp2/3 complex) ARPKD see autosomal recessive polycystic kidney disease (ARPKD) array tomography 2:46-47 arrestin family 2:456 arrestin related trafficking adaptors (ARTS) 2:456 arRP see autosomal recessive retinitis pigmentosa (arRP) ARSACS see autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) ARTEMIS-DNA-PKcs complex, nucleolytic processing by 1:451 arterial thrombosis 1:718 arterial vessels 4:114-115 arthritis 3:25-26, 3:29 ARTS see arrestin related trafficking adaptors",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": ":591 and ATG8/LC3 1:588 Atg12-Atg5-Atg16L complex 2:503 ATGL lipase 2:276 atherosclerosis 3:735 plaque formation 1:177-178 ATL see Atlastin (ATL) Atlas3D software 2:49 Atlastin (ATL) 2:279-281 ATM kinase see ataxia-telangiectasia mutated kinase (ATM kinase) ATM protein see ataxia telangiectasia mutated protein (ATM protein) ATM-related damage response 3:460-461, 3:461F atmospheric pressure chemical ionization (APCI) 4:204-205, 4:204F atmospheric pressure matrix-assisted laser desorption/ionization (AP-MALDI) 1:155 atomic resolution 2:9, 2:22 ATP see adenosine triphosphate (ATP) ATP hydrolysis 1:437, ATPase see adenosine triphosphatase (ATPase) ATPase associated with various cellular activities protein (AAA protein) 2:592 ATPase Brahma (Brm) 3:787 ATPases see AAA-adenosine triphosphatase (ATPases) ATP-dependent chromatin remodeler 1:488 ATRA see all-trans retinoic acid (ATRA) ATR-interacting protein (ATRIP) 3:461 ATRIP see ATR-interacting protein (ATRIP) embrace of 2:782 cargo recognition 3:405-406 in energy economy and nutrient-sensing 1:765-766 induction 3:404-405 lysosomal delivery 3:406 lysosomal diseases and 1:770 macroautophagy 3:405F mechanism 2:244F modulation of host cell autophagy pathways 2:781F mTORC1 suppressing 3:246 pathophysiology 3:408-409 pathway 1:117, 3:404 phosphoinositides in autophagy regulation 2:515-516, 2:516F recycling 3:406-407",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "CSF see cerebrospinal fluid (CSF) CSF-1 see colony stimulating factor-1 (CSF-1) CSF2 see colony stimulating factor 2 (CSF2) CSFV see classical swine fever (CSFV) CSK see C-terminal SRC kinase (CSK) CSL see Lag-2 (CSL) cSMAC see central supramolecular activation cluster (cSMAC) CSP see cysteine-string protein (CSP) CSPGs see CS proteoglycans (CSPGs) CSR see class switch recombination (CSR) CST see Clostridium spiroforme toxin (CST); cystatins (CSTs) CT see cholera toxin (CT) CT694 Chlamydia effector 2:787 CtBP1-S/BARS 2:503 CTCs see circulating tumor cells (CTCs) CTD see C-terminal domain (CTD); carboxy-terminal domain (CTD) C-terminal 99 amino acids of APP (C99) 1:696 C-terminal DIX domain 3:90F C-terminal domain (CTD) p6 domain of Gag 2:832-833 C-terminal portion of BRCA-1 gene (BRCT) 1:451 C-terminal proline-arginine domain (PRD) 2:446 C-terminal SRC kinase (CSK) 3:537 C-terminal a-amidation 1:86-87 CTFs see C-terminal fragments (CTFs) CTGF see connective tissue growth factor (CTGF) CTLA-4 see cytotoxic T-lymphocyte antigen 4 (CTLA-4) CTLD see C-type lectin-like domains (CTLD) CTLs see cytotoxic T lymphocytes (CTLs) cTnI see cardiac troponin I subunit (cTnI) CTP-synthase (CtpS) 2:593 C-type lectin receptors (CLRs) 3:588, 3:595, 3:710, 3:710-712, 3:711T C-type lectin-like domains (CTLD) 2:848, 3:710-712, 3:727 C-type lectins 2:848 C-type natriuretic peptide (CNP) 1:750, 3:58 CUB domain proteins see C1r/C1s, Uegf, and Bmp1 (CUB) domain proteins cubitus interruptus (CI) 3:77-78 cue-mediated polarization of yeast cells 4:51-52, 4:52F Cullin proteins 1:584T, 1:587 Cullin-Ring ubiquitin ligases (CRLs) 1:585, 1:587 cultured cells, long-term fluorescence movies of 2:68 cumulus oophorus complex (COC) 1:636 cup closure 2:760, 2:761 curtaining defects 2:46 curvature 3:193-194 CvpA 2:777 CW STED microscopy see continuous-wave STED microscopy (CW STED microscopy) CWD see chronic wasting disease (CWD) CXC chemokine ligand (CXCL) 3:616 CXC chemokine receptor (CXCR) 3:616 CXCR5 3:543",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "DA see dopamine (DA) DAB see diamiobenzidine (DAB) Dab1 see disabled homolog 1 (Dab1); disabled-1 (Dab1) Dachsous (Ds) 3:100 DAF-2/DAF-16 pathway 2:849-850 DAG see diacylglycerol (DAG); directed acyclic graphs (DAG); driven diacylglycerol (DAG) see death-associated protein kinase (DAPK) DAPK1 see death-associated protein kinase 1 (DAPK1) darbepoetin alfa 1:126 dark zone (DZ) 3:543 dark-state exchange saturation transfer (DEST) 1:98, 1:104-105 DAT see dopamine transporter (DAT) data analysis 1:32-33 frequency-domain data 2:117 time-domain data 2:116-117 data availability 4:247 data integration 4:266 workflow 4:246F data interpretation critical thinking in 4:249 identification of suitable resources and 4:247 data processing inequality (DPI) 4:258 data quality and heterogeneity 4:246-247 data structure standardization 4:247-248 data-dependent acquisition (DDA) 4:167-168 data-driven approach see bottom-up approach data-independent acquisition (DIA) 4:168-169 daughter centriole (DC) 2:649, 2:650F, 2:651, 2:656 DBA see diamond-Blackfan anemia (DBA) DBD see DNA binding domain (DBD) DBI see diazepam binding inhibitor (DBI) Dbl homology domain (DH domain) 2:499, 2:731-733, 3:211 DBL-1 pathway 2:850 DC see daughter centriole (DC); dendritic cells (DCs); dyskeratosis congenita (DC) DCE see downstream core element (DCE) DCF see dihydrodichlorofluorescein (DCF) DCGR8 1:365, 3:788 DCGs see dense core granules (DCGs) Dclk1 see doublecortin-like kinase 1 (Dclk1) DCs see dendritic cells (DCs) Dct see dopachrome tautomerase (Dct) DD see death domain (DD) DDA see data-dependent acquisition (DDA) DdDp see DNA-dependent DNA polymerase (DdDp) DDFT see dynamic density functional theory (DDFT) DDP-IV see dipeptidyl peptidase IV (DDP-IV) DDR see DNA damage response (DDR)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "digalactosyldiglyceride (DGDG) 1:181 DIGE see differential in gel electrophoresis (DIGE) DiGeorge syndrome 1:355, 1:357F, 1:360 digestive proteases 1:732 proteolysis large intestine role in 1:735-736 oral cavity role in 1:732-733 small intestine role in 1:733-735 stomach role in 1:733 digital approach 4:65 dihydroceramides (DHCer) 1:187 dihydrodichlorofluorescein (DCF) 3:816 dihydropyridine receptors (DHPR) 2:679-680 dihydroxy benzoic acid (DHB) 4:178 diisopropyl-phosphofluoridate (DFP) 1:131 dikinase 1:267, 1:268-269 dimensionality reduction approaches 4:257-258 dimeric motors 2:600-601 dimerization domain 3:58 inhibitors 1:744 RTKs undergo ligand-induced 3:9-11 dimethyl sulfate (DMS) 1:27 2,2 0 -dioleoyl isoform 2:205 dipeptidyl aminopeptidase A (DPAPA) 2:478 dipeptidyl peptidase IV (DDP-IV) 1:735, 3:625 DIPG see diffuse intrinsic pontine gliomas (DIPG) diphtheria toxin (DT) 2:796-797 diphtheria toxin receptor (DTR) 3:760-761 dipole orientation 2:64 direct electron detection 2:6, Dishevelled (dsh) 2:746-747 disordered proteins 1:112 cellular phase separations 1:113 coupled folding and binding 1:112 flexible linker 1:112 DISP see dispatched (DISP) dispatched (DISP) 3:76 dissecting biological noise 3:674-675 dissolution 1:461 distal appendages 2:649, 2:650F, 2:653 distal SMAC (dSMAC) 3:522-524, 3:660 distance information sources 1:100 distributive enzyme 1:396 disulfide bond formation 2:162 disulfide bonds 1:125, 1pairing 1:78 dithiothreitol (DTT) 1:69 DivIVA peripheral membrane protein 2:593 DksA 1:476 DLBCL see diffuse large B-cell lymphoma (DLBCL) Dlg see discs-large homolog (Dlg) Dlg1 see Drosophila disc large tumor suppressor (Dlg1) DLK see dual leucinezipper kinase (DLK) DLL1 see delta-like ligand1 (DLL1) Dll4 see delta-like 4 see dynamin-like proteins (DLP) DMS see dimethyl sulfate (DMS) DMT1-II see SLC11a2 iron transporter DMVs see double membrane vesicles (DMVs) DN cell see double negative cell (DN cell)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "FACS see fluorescence-activated cell sorting (FACS) FACT see facilitates chromatin transcription (FACT) F-actin see filamentous actin (F-actin) factor B, molecular mechanisms 1:728-729 factor D, molecular mechanisms 1:728-729, 1:729 factor I, molecular mechanisms 1:729 factor inhibiting HIF-1 (FIH-1) 4:109-110 Factor V Leiden mutation 1:719 FAD see familial AD (FAD); flavin adenine dinucleotide (FAD) FADD see FAS-associated death domain protein (FADD) FADD-likeIL-1b-converting enzyme (FLICE) 3:335 FAK see focal adhesion kinase (FAK) FAO see fatty acid oxidation (FAO) familial AD (FAD) 1:662 familial CJD (fCJD) 2:840 familial hemophagocytic lymphohistiocytosis (FHL) 2:226 FHL1 2:237-239 familial hypercholesterolemia 1:176, 1:178 families of structurally similar proteins (FSSP) 1:94-95 FANCD1/BRCA2 gene 3:777 Fanconi anemia pathway (FA pathway) 1:463 FAP see fibroblast activation protein (FAP) FAPP see four phosphate adaptor proteins (FAPP) farnesoid X-receptor (FXR) see fatty acid synthase (FAS) FAS1 see fasciclin domain (FAS1) FAS-associated death domain protein (FADD) 3:67, 3:335, 3:356-357, 3:393-394 fasciclin domain (FAS1) 3:727, 3:732 fascin 2:687-688 FasL see Fas ligand (FasL) fast atom bombardment (FAB) 1:79 fast scanning 2acid synthase complexes 1:14 fatty acid synthesis, regulation of 1:294 fatty acid a-oxidation 2:254 fatty acid b-oxidation 2:252, 2:253F fatty acids 1:154 fatty acyls 1:153-154 F-BAR domain group see FCH-BAR-Fes/CIP4 homology-BAR domain group (F-BAR domain group) F-BAR extension domain (FX domain) 2:499-500 FBN1 see fibrillin-1 (FBN1) FBP17 see formin-binding protein 17 (FBP17) FC see fibrillar centre (FC) FCC see focal chemotactic chambers (FCC) FCCS see fluorescence cross-correlation spectroscopy (FCCS) FCH-BAR-Fes/CIP4 homology-BAR domain group (F-BAR domain group) 2:491, 2:494F fCJD see familial CJD (fCJD) FCMD see Fukuyama congenital muscular dystrophy (FCMD) FcR see receptors for Fc portion of immunoglobulins (FcR) FCS see fluorescence correlation spectroscopy (FCS) Fcg receptor (FcgR) 2:752, 2:766-767, 3:695 activation by IgG 3:696-697 FDA see Federal Drug Administration (FDA); US Food and Drug Administration (FDA) FDC see follicular dendritic cells (FDC) FDCs see follicular dendritic cells (FDCs) Fdx see fluorescein dextran (Fdx) fecal transplants 2:801, 2:804 fed state metabolism in 1:290 action of insulin 1:290 glucose metabolism in liver 1:290-291 substrates (fuel) availability 1:289 Federal Drug Administration (FDA) 3:821 feedback 4:32, 4:32-33, 4:32F, 4:33 graphical understanding of 4:31 negative 4:30-31, 4:31F, 4:33, 4:33F",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "Fourier space 2:86-87 14-3-3 proteins 2:503 FOX-C2 see forkhead-C2 (FOX-C2) FoxO transcription factors 3:781 FoxO3a see transcriptional activity of Forkhead box O3 (FoxO3a) FoxP3 3:576-577 FPALM see fluorescence photoactivation localization microscopy (FPALM) FPR see fluorescence photobleaching recovery (FPR) fps see frames per second (fps); Fujinami poultry sarcoma (fps) Fps/Fes 2:499-500 fraction collector 1:75 fractional diffusion cardiac models 4:90 fractionation methods 4:180 fracture-label 2:39 fragment screening 1:744 frames per second (fps) 2:81 FRAP see fluorescence recovery after photobleaching (FRAP) Frasier syndrome 1:501 FRB see FKBP12-rapamycin-binding (FRB) FRCs see fibroblastic reticular cells (FRCs) free energy 1:298 freeze etching 2:20 freeze-fracture replica labeling (FRL) 2:39-40, 2:39-40, 2:40F freeze-substitution 2:34-36 freezing/thawing 2:36-37 frequency-domain data 2:see freeze-fracture replica labeling (FRL) front loading 4:29 front-back polarity 2:726-727 FRS2 see FGF receptor substrate 2 (FRS2) frustrated phagocytosis 3:729 FSC see Fourier Shell Correlation (FSC) FSM see fluorescence speckle microscopy (FSM) FSP-1 see fibroblast specific protein 1 (FSP-1) FSP27 2:274 FSSP see families of structurally similar proteins (FSSP) FST see follistatin (FST) FTase see farnesyltransferase (FTase) FtsA filaments 2:590 FtsZ filaments 2:590 5-FU see 5-florouracil (5-FU) functional cell biology of immunity 3:518-527 adaptive immunity elements 3:519 barriers and tissue cells 3:519 cell biology 3:518-519 chemical defenses 3:519-520 evolution 3:526 ILC 3:521-522 immunological synapses 3:522-525, 3:524F innate immunity elements 3:519 LT 3:525-526 lymphocytes 3:522 model immunological synapse 3:523 phagocytes and receptors 3:521 sensing mechanisms 3:520-521 fucose (Fuc) 2:339-340 Fujinami poultry sarcoma (fps) 2:499-500 Fukuyama congenital muscular dystrophy (FCMD) 2:348-349 full width at half maximum (FWHM) 2:113 functional aspects of cell biology 3:-to-find domain (FIIND) 3:717 fungal sex 2:254 FunWalk 4:213 furin 1:555-556, 1:556, 1:556, 1:556F, 1:558, 1:562, 1:562-563, 1:563, 1:563-564, 1:564, 1:564T cleavage of prodomain 1transport carrier 2:371 fusogenic proteins 2:461-463 futile cycles 4:29-30 FWHM see full width at half maximum (FWHM) FX domain see F-BAR extension domain (FX domain) FXR see farnesoid X-receptor (FXR) FYCO 1 see FYVE and coiled-coil domain containing protein 1 (FYCO 1) FYN tyrosine kinase 3:420 FYVE and coiled-coil domain containing protein 1 (FYCO 1) talk between GPCRs and RTK pathways 3:51F growth factor receptors and 3:51-52 signaling pathways 3:51 G proteins see GTP-binding proteins (G proteins) G0 see quiescence G1 phase 3:424, 3:424-425, 3:426 G1/S DNA damage checkpoint 3:436 G3P see glyceraldehyde-3-phosphate (G3P); glycerol-3-phosphate (G3P) GA see gibberellic acid (GA); Golgi apparatus (GA) GABA see gamma-aminobutyric acid (GABA) G-actin binding proteins 2:554-557 sequestering proteins 2:556 transport 4:13 GADD153 see growth-arrest and DNA damage inducible protein (GADD153) GAE homology see gamma-adaptin ear homology (GAE homology) GAF see gamma-activated factor (GAF) Gag coordinates HIV assembly 2:829-832 Gag oligomerization 2:830 GAGs see glycosaminoglycans (GAGs) gain-of-function proteotoxicity 1:792 gal operon 1:475 Gal see galactose (Gal) galactose (Gal) 1:271, 2:339-340 galactosialidosis 1:774 galactosylcer amides (GalCer) 1:184, 1:187 GalCer see galactosylcer amides (GalCer) GalNAc see N-acetylgalactosamine (GalNAc) interferon-inducible lysosomal thiolreductase (GILT) 3:590, 3:591 gamma-activated factor (GAF) 3:143 gamma-adaptin ear homology (GAE homology) 2:453 gSA see g-specific array (gSA) g-secretase see also b-Secretase identification and mechanism 1:664 inhibitors and modulators 1:665 other substrates 1:664-665 prospects for therapeutics 1:666 structure elucidation 1:665-666 g-specific array (gSA) 3:153 g-tubulin ring complex (g-TuRC) 2:638, 2:653 Gap period (G1phase) 3:447 GAP see GTPase activating protein (GAP); guanosine-activating protein (GAP) ganglion mother cell (GMC) 2:747 ganglioside M1 (GM1) 1:209-210 ganglioside-induced differentiationassociated protein 1 (GDAP1) 2:285-286 gangliosides 1:149, 1:155 gap genes 4:66 GAP-43 see growth-associated protein-43 (GAP-43) GAPs see GTPase activating proteins (GAPs) GARP see Golgi-associated retrograde protein (GARP) gas chromatography (GC) 4:203, 4:203-204, 4:204-205 Gas6 see growth arrest-specific gene 6 (Gas6) GAS7 see growth arrest-specific protein (GAS7) gastric carcinoma (GC) 3:146 gastric development, role in 1:685-686 gastric ulcer 1:677 gastrointestinal stromal tumor (GIST) 3:17 GAT see GGA and Tom (GAT) gated image intensifiers, time-domain wide-field FLIM by 2:779-780, 1:779, 1:780, 1:781, 1:782, 1:783, 1:785 chronic neuronopathic 1:772 comorbid associations of 1:772-773 B-cell lymphoma and myelomatosis see glycan-binding proteins (GBPs) GBSS see granule-bound starch synthase (GBSS) GC see gas chromatography (GC); gastric carcinoma (GC); germinal center (GC); granular component (GC); guanylyl cyclases (GCs) GCA 3:58 GCB see germinal center B cell (GCB) GCC see guard cell chloroplasts (GCC) GCC88 2:436, 2:437 GCC185 2:436, 2:437 GCL see granule cell layer (GCL) G-clathrin see gyrating-clathrin (G-clathrin) GC-MS 4:203-204, 4:205-206, 4:205F, 4:206F, 4:207 G-CSF see granulocyte colony-stimulating factor (G-CSF) G-CSFR see granulocyte-colony stimulating factor receptor (G-CSFR) GDAP1 see ganglioside-induced differentiation-associated protein 1 (GDAP1) GDF see GDP displacement factor (GDF); growth and differentiation factors (GDFs) GDI see GDP-dissociation inhibitor (GDI); guanine nucleotide displacement inhibitor (GDI) GDNF see glial-derived neurotrophic factor (GDNF) GDP displacement factor (GDF) 2:443 GDP see guanosine diphosphate (GDP) GDP-bound inactive state 2:795-796 GDP-dissociation inhibitor (GDI) 2:402, 2:443, 3:703-704 GDP-GTP exchange factor (GEF) 3:494-495 GDP-tubulin 2:541 GED see GTPase effector domain (GED) GEEC pathway see GPI-anchored proteinenriched early endosomal compartment (GEEC pathway) GEF see GDP-GTP exchange factor (GEF); GTP exchange factors (GEFs); guanine exchange factor (GEF); guanine nucleotide exchange factor (GEF) gelatinase granules (GG) 2:770 gelatinases 1:621-622 gene assembly from DNA microarrays 1:49-50 gene duplication 1:81 gene editing 1:515 gene encoding lysosomal intrinsic membrane protein (LIMP-2) 1:773-774 gene expression profiling technologies 4:252 variability in 4:220 administration of vectors to the brain 1:784 indirect use of vector-transduced autologous hematopoietic stem-cells 1:784-785 gene trap 1:514 general control nonderepressing 2 1:309 general control nonderepressing 4 1:309 general transcription factor (GTF) 1:481 generalized lymphoproliferative disease (gld) 3:70 generalized myotonia 1:231 generation of noncoding ncRNA 3:785 genes, proteins and 4:216 genetic fate mapping 4:137-138 genetic clonal evolution theory 3:807 genetic code 1:310-313, 1DNA damage and repair 3:777 telomere shortening 3:777 disorders 3:691-692 genetically encoded fluorescent probes 2:52 see also fluorescent proteins breaking diffraction barrier 2:56 competing parameters for optimal imaging 2:58F imaging cells in whole organisms 2:54-56 technical considerations for live imaging 2:56-59 uses 2:59-60 genome sequencing for interactome mapping 4:193 genome stability 1:461 genome wide chromatin immunoprecipitation data (GW-ChIP) stem cells (GSCs) 2:656 germline transcription 3:555 gerontoplast 2:327 Gerstmann-Str\u00e4ussler-Scheinker (GSS) syndrome 2:839, 2:840 GET pathway see guided entry of TA proteins pathway (GET pathway) GF organisms see germ-free organisms (GF organisms) GFAP see glial fibrillary acidic protein (GFAP) GFP see green fluorescent protein (GFP) GFR signaling see growth factor receptor (GFR) signaling GG see gelatinase granules (GG) GGA and Tom (GAT) 2:453 GGAs see Golgi localized g-ear-containing ARF-binding proteins (GGAs) GGT see geranylgeranyl transferase (GGT) GHK equation see Goldman-Hodgkin-Katz (GHK) equation GHR see growth hormone receptor (GHR) GI see glucosidase I (GI) giant plasma membrane vesicles (GPMV) 1:212 gibberellic acid (GA) 2:324 Gibbs free energy 1:5-6 additive changes 1:6-7 decreases for spontaneous process 1:6 GII see glucosidase II (GII) Gillespie algorithm 4:58 GILT see gamma interferon-inducible lysosomal thiolreductase (GILT) GIST see gastrointestinal stromal tumor (GIST) GL see glomerular layer (GL) GL1001 see MLN-4760 glass-SLBs see glass-supported artificial lipid bilayers (glass-SLBs) glass-supported artificial lipid bilayers (glass-SLBs) 3:661 Glc see glucose (Glc) GlcA see glucuronic acid (GlcA) GlcCer see glucosylceramides (GlcCer) GlcNAc see N-acetylglucosamine (GlcNAc) gld see generalized lymphoproliferative disease (gld) Gle2-binding-sequence (GLEBS) 3:300 GLEBS see Gle2-binding-sequence (GLEBS) GLFG see Gly-Leu-Phe-Gly (GLFG) GLI1 see GLI-Kruppel family member GLI1 (GLI1) glia maturation factor (GMF) 2:559 glial fibrillary acidic protein (GFAP) tail domain (GTD) 2:445 globule 1:793 globulins 2:382 glomerular layer (GL) 4:135F Glu78 glutamic acid residue 1:304 glucagon action of 1:294 and metabolic processes 1:289 signaling pathway 1:295F glucan phosphatase 1:268-269 glucan water dikinase (GWD) 1:268-269 glucocorticoid-stimulated kinase (SGK) glucose metabolism in liver during fasting 1:295-296 fatty acid oxidation and ketogenesis 1:296 gluconeogenesis, regulation of 1:296 glycogen degradation, regulation of 1:295-296 fed state 1:290-291 fatty acid synthesis, regulation of 1:294 glycogen synthesis, regulation of 1:291-292 glycolytic pathway, regulation of 1:292-293 protein synthesis 1:294 pyruvate dehydrogenase complex, regulation of 1:293-294 transport and phosphorylation of glucose 1:290-291 pathways involved in 1:289F glucose transporter 3 (GLUT3) 3:336 glucose transporter 4 (GLUT4) receptors 2:608 glutamate-ammonia ligase (GLUL) 3:344 glutaminyl cyclase inhibitor 1:123-124 glutathione (GSH) 3:336 glutathione S-transferase (GST) 1:73 glycan 1:599 glycan headgroup addition 1:189-190 glycan-binding proteins (GBPs) 2:343 glycans 2:162-163 glyceraldehyde-3-phosphate (G3P) 2:328-329 glycerol-3-phosphate (G3P) 2:276 glycerolipid 1:154-155, 1:160, 2:273 phosphatidic acid synthesis 1:161-162 phospholipids synthesis in bacteria 1:162 amine-containing phospholipids synthesis 1:162 non-amine-containing phospholipids synthesis 1:162-164 phospholipids synthesis in eukaryotes 1:164 amine-containing phospholipids synthesis 1:164-166, 1:165F non-amine-containing phospholipids synthesis 1:166-169 physical and chemical properties 1:169F roles of phospholipids in cell function 1glycine-and serine-rich domain (GS domain) 3:39-40 glycocalyces 1:280-281 catabolism of 1:281F hyaluronan-dependent 1:281F glycocalyx matrix 3:193 glycogen 1:263-264, 1:764, 1:764-765, 1:767, 1:768, 1:768-769, 1:769, 1:770, 1:771-772, 1:772, 1:779 degradation 1:266-267, 1:295-296 enzyme activities 1:266F",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "loop 2:833 GPCR see G-protein coupled receptor (GPCR) GPCRs see G protein-coupled receptors (GPCRs) GPI see glycosylphosphatidylinositol (GPI) GPI-anchored protein-enriched early endosomal compartment (GEEC pathway) 2:394 GPI-anchored proteins see glycosylphosphatidylinositol (GPI)-anchored proteins GPI-anchored serine proteases 1:651-652 GPMV see giant plasma membrane vesicles (GPMV) G-protein coupled receptor (GPCR) GPS see gray platelet syndrome (GPS) GPU see graphical processing units (GPU) G-quadruplexes 1:427 gram negative pathogens 2:845-846 gram-negative bacteria 1:160, 2:588 gram-negative pathogens 2:777 gram-negative Pseudomonas fluorescens 1:57 gram-positive bacteria 1:160, 2:588, 2:845-846 granular component (GC) 3:254 granulation tissue formation 3:219-220 granule cell layer (GCL) 4:135F granule-bound starch synthase (GBSS) 1:267-268 granule cells 4:134, 4:135F, 4:137, 4:138 granulocyte colony-stimulating factor (G-CSF) 3:626, 3:750 granulocyte-colony stimulating factor receptor (G-CSFR) 3:140-141 granulocyte-macrophage colony-stimulating factor (GM-CSF) 3:24, see guide RNA (gRNA) GRNs see gene regulatory networks (GRNs) GroEL 1:105 GroEL-ES 2:9-11, 2:10F ground-state depletion after individual molecule return imaging (GSDIM) 2:76, 2:81 biological applications to biological research 2:82-84 biological sample preparation 2:81-82 commercial microscopes 2:81 ground-state depletion microscopy (GSD microscopy) 2:76 see also stimulated emission depletion (STED) microscopy scanning 2:81 growth and differentiation factors (GDFs) 3:37 GDF11 3:779 growth arrest-specific gene 6 (Gas6) 2:753-754, 3:375 growth arrest-specific protein (GAS7) 2:497 growth cone 3:209-210, 3:233 growth factor receptor (GFR) signaling 2:758 effect on macropinocytosis 2:759 and GPCRs 3:51-52 growth factor receptor-bound protein 2 (GRB2) 3:119, 3:534-535 growth factor signaling 1:766, 1:766, 1:771, 3:5 growth factors, mTOR signaling regulation by 3:246-247 growth hormone receptor (GHR) 3:141 growth-arrest and DNA damage inducible protein (GADD153) 2:531-532 growth-associated protein-43 (GAP-43) 3:235-236 GRP78 see glucose-regulated protein of 78 kDa (GRP78) GRP94 see glucose-regulated protein of 94 kDa (GRP94) GS see Griscelli's syndrome (GS) GS domain see glycine-and serine-rich domain (GS domain) Gsa 3:52 Gsa-induced neurite outgrowth 3:52 translocation 3:53F GSCs see germline stem cells (GSCs) GSD microscopy see ground-state depletion microscopy (GSD microscopy) GSDIM see ground-state depletion after individual molecule return imaging (GSDIM) GSDs see glycogen storage diseases (GSDs) GSH see glutathione (GSH) GSK3 see glycogen synthase kinase 3 (GSK3) GSK3b see glycogen synthase kinase 3 beta (GSK3b) GSS syndrome see Gerstmann-Str\u00e4ussler-Scheinker (GSS) syndrome GST see glutathione S-transferase (GST) GSV see GLUT4 storage vesicles (GSV) GTD see globular tail domain (GTD) GTF see general transcription factor (GTF) GTP see guanosine triphosphate (GTP) GTP exchange factors (GEFs",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "PDE 3:59-60 pGCs 3:57-58 sGCs 3:56-57 guard cell chloroplasts (GCC) 2:329, 3:58-59 guardian of genome 3:504 guide RNA (gRNA) 1:515 guided entry of TA proteins pathway (GET pathway) 1:597-598 gut microbiome see microbiome gut-associated lymphoid tissue (GALT) 3:690 GW182 1:349, 3:321-322 GWAS see genome-wide association studies (GWAS) GW-ChIP see genome wide chromatin immunoprecipitation data (GW-ChIP) GWD see glucan water dikinase (GWD) GXNA see gene expression network analysis (GXNA) gyrating-clathrin (G-clathrin) 2:389 H H 2 O 2 see hydrogen peroxide (H 2 O 2 ) H3 see histone 3 (H3) H3K4me3 see histone H3 at residue K4 (H3K4me3) HA see hemaglutinin (HA); hyaluronan (HA); hyaluronic acid (HA) HA receptor for endocytosis (HARE) 1:282 HAART see highly active antiretroviral therapy (HAART) see HTT-associated protein 1 (HAP1) HAP40 see Htt associated protein (HAP40) haploid yeast cells 4:51-52 haploinsufficiency 1:448 of Kif1b gene 2:614 haptotaxis 3:209 see also chemotaxis HARE see HA receptor for endocytosis (HARE) HARE/stabilin-2 1:282, 1:285 systemic clearance of hyaluronan by 1:283F HAS see hyaluronan synthase (HAS) HAT like-1 (HATL-1) 1:654, 1:654-655 HAT like-4 (HATL-4) 1:654-655 HAT like-5 (HATL-5) 1:654-655 HAT see human airway trypsin-like (HAT); histone acetyltransferases (HATs) HAV see hepatitis A virus (HAV) Hayflick limit 3:777 HB see heparin-binding (HB) HB-EGF see heparin-binding epidermal growth factor (HB-EGF) Hbs1 3:320 HBV see hepatitis B virus (HBV) HbYX motif 1:589, 1:590, 1:590F HCA see high-content analysis (HCA) hCAP-18 see human cationic antimicrobial protein-18 (hCAP-18) HCC see hepatocellular carcinoma (HCC) HCD see higher collisional dissociation (HCD); higher energy collisional dissociation (HCD) HCS see Hajdu-Cheney syndrome (HCS); high-content screening (HCS) HCV see hepatitis C virus (HCV) HCxS see high complexity screening (HCxS) HD see heterodimerization domain (HD); Huntington's disease (HD) HDAC see histone deacetylase complexes",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "3:3, 3:369F, 3:809 hypoxia response element (HRE) polymorphism see insertion/deletion polymorphism (I/D polymorphism) i-AAA protease see IMS AAA-protease (i-AAA protease) IAD see inner-arm dyneins (IAD) IAP see inhibitor of apoptosis protein (IAP); inhibitors of apoptosis (IAPs) IAP-binding motifs (IBMs) 1:708, 3:390 IAP-like protein 2 (ILP-2) 1:707-708 iatrogenic CJD (iCJD) 2:840 IAV see influenza A virus (IAV) iBALT see inducible bronchus-associated lymphoid tissue (iBALT) I-BAR proteins 2:491, 2:497 domain-containing proteins 2:494F IBD see inflammatory bowel disease (IBD) IBMs see IAP-binding motifs (IBMs) ibrutinib 1:131 IC see intermediate chains (IC); intermediate compartment (IC) ICAD cleavage see inhibitor of caspase activated DNase (ICAD) cleavage ICAMs see intercellular cell adhesion molecules (ICAMs) ICAT see isotope-coded affinity tags (ICAT) ICB see intercellular bridge (ICB) ICE see interleukin I converting enzyme (ICE) iceberg model 1:10-11 I-cell disease 1:773-774, 1:777-778 see also Inclusion-cell disease (I-cell disease) action myoclonus-renal failure syndrome (AMRF) 1:773-774 ICG see International Cancer Consortium (ICG) iCJD see iatrogenic CJD (iCJD) ICL see interstrand cross-links (ICL) ICM see inner cell mass (ICM) ICMT see isoprenylcysteine carboxyl methyltransferase (ICMT) ICOS see inducible co-stimulator (ICOS) ICOS ligand (ICOSL) 3:541 icosahedron 1:517, 1:520 ICOSL see ICOS ligand (ICOSL) ICS see image correlation spectroscopy (ICS) icythosis lamellaris 1:772 IDAs see inner dynein arms (IDAs) IDDs see intrinsically disordered domains (IDDs) see isoelectric focusing (IEF) IEX chromatography see ion-exchange chromatography (IEX chromatography) iFBA see integrated flux-balance analysis (iFBA) iFGFs see intracellular FGFs (iFGFs) IFI16 see IFN-g inducible protein16 (IFI16) IFN see interferon (IFN) IFN gamma receptor (IFNGR) 3:30 IFN lambda receptor (IFNLR) 3:30 IFNGR see IFN gamma receptor (IFNGR) IFNLR see IFN lambda receptor (IFNLR) IFN-stimulated gene 3 (ISGF3) 3:143 IFN-stimulated genes (ISGs) 3:720-721 IFN-g inducible protein16 (IFI16) 3:719-720 IFs see intermediate filaments (IFs) IFT see intraflagellar transport (IFT) Ig see immunoglobulin (Ig) Ig heavy (IgH) 3:552 IGC see immature granule cells (IGC) IGCEERSFPNIIIIIG peptide 1:684 IGF see insulin-like growth factor (IGF) IGF-1 see insulin-related growth factor-1 (IGF-1) IGF-BP see insulin-like growth factor binding protein (IGF-BP) IgH see Ig heavy (IgH) Ig-like see immunoglobulin-like (Ig-like) iGluRs see ionotropic glutamate receptors (iGluRs) IGR see intergenic region (IGR) IGS see intergenic spacer (IGS) IHC see immunohistochemistry (IHC) iHeps see iPS-derived hepatocytes (iHeps) IHH see Indian HH (IHH) IKK see inhibitor of kappa B kinase (IKK) IL see interleukin (IL) IL-1 receptor (IL-1R) 3:28 IL-1R1 3:28 IL-1R2 3:28 IL-1R3 3:28-29 IL-1R3b 3:29 therapeutic targeting 3:29 IL-1R see IL-1 receptor (IL-1R); interleukin 1 receptor (IL-1R) IL-1R-associated kinases (IRAKs) 3:712-714 IL-2 inducible T cell kinase (ITK) 3:534-535 IL-3Ra see a-subunit of IL-3 receptor (IL-3Ra) IL-10/IL-22 receptors 3:29-30 ILCs see innate lymphoid cells (ILCs) ILK see integrin-linked kinase (ILK) ILP-2 see IAP-like protein 2 (ILP-2) ILPs see invadopodia-like protrusions (ILP); invadosome-like protrusions (ILPs)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "FRET 3:663F imaging TCR-pMHC interactions in situ 3:661-664 measuring binding in situ 3:661 membranes 3:661 pulling forces 3:664-665 2D-binding constants micropipette and bioforce probe measurements 3:662F immunoproteasome 1:591, 1:592, 3:591 and alternative CP subunits 1:591 immunoreceptor tyrosine-based activation motifs (ITAMs) see intermembrane space (IMS); ionmobility spectrometry (IMS) IMS AAA-protease (i-AAA protease) 2:282-283 IMS-RP see intermembrane space reporter protein (IMS-RP) IN see integrase (IN) in situ, measuring binding 3:661 in vitro SV40 DNA replication system 1bronchus-associated lymphoid tissue (iBALT) 3:619 inducible co-stimulator (ICOS) 3:541 inducible nitric oxide synthase (iNOS) 2:767, 2:767-768, 3:61 induction, autophagy 3:404-405 INF2 see inverted formin (INF2) infancy, changes in gut microbiome in 2:801-802",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "formin (INF2) 2:285 IOMA see integrative omics-metabolic analysis (IOMA) ion abrasion scanning electron microscopy (IA-SEM) see focused ion beam scanning electron microscopy (FIB-SEM) ion channel allostery neuronal action potentials and 1:244-251 ion channel gating 1:229 ion channel kinetics 4:86 ion channel selectivity, quantification of 1:231-232, 1:233F ion channels optochemical approaches to controlling 2:151-153 ion movement, electrochemical driving force for 1:221, 1:221-223, 1:235 ion suppression 4:207 ion transport and cystic fibrosis 1:255 ion-exchange chromatography (IEX chromatography) 1:71 ionizing radiation 1:442, 1:445-446 ion-mobility spectrometry (IMS) 1:152 ionotropic glutamate receptors (iGluRs) 2:151 ionotropic receptors 1:244, 1:248see inhibitory postsynaptic potentials (IPSP) IPTG see isopropyl-b-D-1thiogalactopyranoside (IPTG) IQ motif 2:597 IR light see infrared light (IR light) IRAKs see IL-1R-associated kinases (IRAKs) IRAP see insulin-regulated aminopeptidase (IRAP) IRC see interference reflection contrast (IRC) IRE see inositol requiring enzyme (IRE); iron response element (IRE) IRES see internal ribosome entry site (IRES) IRF see instrument response function (IRF); interferon regulatory factor (IRF) iRhom2 see inactive Rhomboid-like protein 2 (iRhom2) iRhoms 1:642-643 IR-MALDI-o-TOF MS see infrared matrixassisted laser desorption/ionization orthogonal time-of-flight mass spectrometry (IR-MALDI-o-TOF MS) iron response element (IRE) 1:343, 1:344 iron sequestration 2:771 iron-containing type 5 purple acid phosphatase (Acp5) 1:776, 1:778 iron-sulfur protein (ISP) 1:301 irreversibility 4:29 IRS family see insulin receptor substrate family (IRS family) IRS-1 see receptor substrate-1 (IRS-1) ISC see intersystem crossing (ISC) ISG15 (IFN-stimulated gene 15 kDa) 1:584T, 1:587-588 ISGF3 see IFN-stimulated gene 3 (ISGF3) ISGs see IFN-stimulated genes (ISGs) ISHAS see International Society for Hyaluronan Sciences (ISHAS) I-SMADs see inhibitory SMADs (I-SMADs) isobaric tags for relative and absolute quantitation (iTRAQ) 4:169, 4:182 isodesmic self-assembly 2:548, 2:552 isoelectric focusing (IEF) 1:66, 1:571 isoelectric point 1:66 isolated cell analysis 4:202 isolation membrane see phagophore isomiRs 1:368-369 isoprenoids synthesis 2:254 isoprenylation 2:312-313 isoprenylcysteine carboxyl methyltransferase (ICMT) 2:312-313 isopropyl-b-D-1-thiogalactopyranoside (IPTG) 1:57 isotachophoresis 1:66, 1:73 isotope-coded affinity tags (ICAT) 4:169 isotype switching 3:581 isozymes/isoenzymes 1:288 ISP see iron-sulfur protein (ISP) ISs see immunological synapses (ISs) ITAMs see immunoreceptor tyrosine-based activation motifs (ITAMs) ITGAM see integrin alpha M (ITGAM) ITIMs see immunoreceptor tyrosine-based inhibitory motifs (ITIMs) ITK see IL-2 inducible T cell kinase (ITK) ITP see immune thrombocytopenic purpura (ITP) iTRAQ see isobaric tags for relative and absolute quantitation (iTRAQ) Ivacaftor 1:252, 1:261 IVM see intravital microscopy (IVM) IVS see intervening sequence (IVS) IVT see in vitro transcription (IVT) IkB see inhibitor of kappa B jaguar mutation 4:122 JAK pathway see Janus kinase pathway (JAK pathway) JAK-homology domains (JH domains) 3:136-140 JAK-STAT 3:2 JAK-STAT-SOCS signaling cascade 3:136, 3:140F and human disease JAK proteins in 3:145-146 SOCS proteins in 3:146-147 STAT proteins in 3:146 JAK family 3:136-141 SOCS proteins 3:144 STAT proteins 3:142-144 in vivo phenotypes 3:137-139T JAMMs see JAB1/MPN/MOV34 (JAMMs) JAMs see junctional adhesion molecules (JAMs) Janus kinase pathway (JAK pathway) 3:136, 4:66 activation signaling downstream 3:142 evolution 3:136-141 in human disease 3:145-146 mechanism of activation 3:141-142 Japanese Electron Optical Corporation (JEOL) 2:16-17 JARID1B 3:809 jasmonates 2:254 JEOL see Japanese Electron Optical Corporation (JEOL) JH domains see JAK-homology domains (JH domains) JIP1 see JNK-interacting protein 1 (JIP1) JMJD3 see Jumonji domain-containing 3 (JMJD3) JMML see juvenile myelomonocytic leukemia (JMML) JMY protein see junction mediating regulatory protein (JMY protein) Jnk see jun Kinase (Jnk) 's sarcoma herpes virus (KSHV) 3:717 Kaposi's sarcoma-associated herpesvirus 2:836 kappa-caseinoglycopeptide 1:733 karyopherin 2:320 KAYAK see kinase activity assay for kinome profiling (KAYAK) KCa3.1 see calcium-activated potassium channel (KCa3.1) 75-kDa 5-phosphatase (Inpp5b) 2:504 KDEL see lysine aspartate glutamate leucine (KDEL) KDR see vascular endothelium growth factor receptor (VEGFR) KEGG 4:211 keloids 3:220 keratan sulfate (KS) 1:271 keratin 15 (K15) 3:794-795 keratinocyte 1:685, 2:569, 2:572-573, 2:574-575, 3:219, see keratinocyte growth factor (KGF) KHCs see kinesin heavy chains (KHCs) KHD see kinase homology domain (KHD) KIF4 see kinesin-4 family member (KIF4) KIF5A see kinesin 5A (KIF5A) KIF13A see kinesin family 13A (KIF13A) KIFC3 see kinesin superfamily protein 3 (KIFC3) KIFCs see kinesin-14 motors (KIFCs) KIFs see kinesin superfamily proteins (KIFs) kinase activity assay for kinome profiling (KAYAK) 4:227-228 kinase cascades 4:44-45 see also mitogen-activated protein kinases (MAPK) pathway kinase homology domain (KHD) 3:58 kinase inhibitor proteins (KIP) 3:437 kinase inhibitory regions (KIRs) 3:144-145 kinase inhibitory proteins (Kip) 3:448 kinase signaling 3:274-275 kinase translocation reporters (KTRs) 4:222 kinases 4:44 kinase-substrate interactions 4:phylogeny and nomenclature 2:609-611 in neurons 2:612F regulation 2:614, 2:616F autonomous regulation of kinesin motility 2:616-617 kintoun (ktu) 2:631-632 KIP see kinase inhibitor proteins (KIP) KIRs see kinase inhibitory regions (KIRs) 'kiss and run' fusion 2:298-299 hypothesis 2:412 transport model 2:186 kit-on-a-lid-assay (KOALA) 3:672 KLCs see kinesin light chains (KLCs) Klf4 see Kruppel-like factor 4 (Klf4) KLK see kallikrein (KLK) KLK1 see tissue KLK KLK8 1:702 KLKs see kallikrein-related peptidases (KLKs) Klumperman's group 2:358 knock out 2:528 Knockin alleles 1:514, 1:515 knockout (KO) 1:514 control 2:41-42 mice 1:662-663, 2:843 KO studies see mouse knockout studies (KO studies) KOALA see kit-on-a-lid-assay (KOALA) Kozak sequence 1:343 Krabbe disease 1:780-781, 1:781 Krebs cycle see tricarboxylic acid (TCA) cycle Kruppel-like factor 4 (Klf4) 3:104 KS proteoglycans (KSPGs) 1:271 KS see keratan sulfate (KS) KSHV see Kaposi's sarcoma herpes virus (KSHV) KSPGs see KS proteoglycans (KSPGs) KSPs see kinesin spindle proteins (KSPs) KTRs see kinase translocation reporters (KTRs) ktu see kintoun (ktu) Ku80 3:779 Kuzbanian (KUZ) 1:643-644, 1:644 L L2A see lysosome-associated membrane protein type 2A (L2A) LA see LDL receptor type A (LA) lab on a chip 3:670-671F, 3:673F LaB6 see lanthanum hexaboride (LaB6) label-fracture 2:39 label-free quantification 4:169 label-retaining cells (LRCs) 3:794-795 laboratory of genetics and physiology 2 (LGP2) 3:718-719 lac promoter 1:475 LacCer see lactosylceramide (LacCer) lactate dehydrogenase (LDH) intermediate filaments 2:571, 2:573 lamina-associated polypeptide (LAP) 2:315 lamin-associated domains (LAD) 2:313 laminin-5 g2 fragment levels 1:624 laminins 2:695-696 laminopathies 2:313, 2:315 LAMPs see lysosome-associated membrane proteins (LAMPs) Land's cycle 1:205 Langerhans cells and migratory DCs 3:595-596 lanthanum hexaboride (LaB6) 2:14 LAP see lamina-associated polypeptide (LAP) large cargo 2:356 transport 2:358-359 large intestine role in proteolysis 1:735-736 large subunit 3:297, 3:300 large subunit of ribosome (RPL) 3:281 large-scale phosphoproteomics strategies 4:179-180, 4:179F lariat 1:495, 1:495-496, 1:496F, 1:498-499, 1:498F, 1:499-500 laser beam 2:65 laser capture microdissection (LCM) 4:218, 4:220-221 laser illumination 2:66-67, 2:66F laser scanning frequency-domain FLIM by 2:116 time-domain FLIM by 2:114-115 last common eukaryotic ancestor (LCEA) 2:183 last eukaryotic common ancestor (LECA) 2:442 last universal common ancestor (LUCA) 1:396, 1:397 clamp loader in 1:401-403 mechanism 1:401-403 structure analysis 1:403 DNA synthesis 1:397-398 protein synthesis in 1LBD see lipid-binding domain (LBD) LBPA see lysobisphosphatidic acid (LBPA) LBPs see lipid-binding proteins (LBPs) LBR see Lamin B receptor (LBR) LC see light chains (LC); liquid chromatography (LC); liquidchromatography (LC) LC3/GABARAP/GATE16 (Atg8) 2:504 LCAT see lecithin:cholesterol acyltransferase (LCAT) LCCs see lineage-committed cells (LCCs) LCEA see last common eukaryotic ancestor (LCEA) LCK see lymphocyte-specific protein tyrosine kinase (LCK) LCM see laser capture microdissection (LCM) LC-MS 4:204-205, 4:205F, 4:206-207, 4:208F LC-MS/MS see liquid chromatography-tandem mass spectrometry (LC-MS/MS) LCMV see lymphocytic choriomeningitis virus (LCMV) LCV see Legionella-containing vacuole (LCV) LDA see limit-dextrinase (LDA) LDGs see low-density granulocytes (LDGs) LDH see lactate dehydrogenase (LDH) LDL receptor type A (LA) see low-density lipoprotein (LDL) LDLA see low density lipoprotein receptor class A (LDLA) Ldlr see low-density lipoprotein receptor (Ldlr) LDLRA domain see low density lipoproteinreceptor class A-like domain (LDLRA domain) and memory 2:611 least squares (LS) 4:257-258 LEC see lymphatic endothelial cells (LEC) LECA see last eukaryotic common ancestor (LECA) lecithin:cholesterol acyltransferase (LCAT) see light emitting diodes (LEDs); lightemitting diodes (LEDs) LEF (lymphoid enhancer-binding factor) 3:94, 3:94F left-right determination 2:611 LegA9 mutants 2:781-782 LEGI mechanism see local excitation, global inhibition mechanism (LEGI mechanism) Legionella pneumophilia (L. pneumophilia) 2:405, 2:777 Legionella T4SS SdhA protein 2:779-780 Legionella-containing vacuole (LCV) 2:779 Legs at odd angles (Loa) 3:238 Lemur tyrosine kinase 2 (LMTK2) 2:415 lentiviruses 2:828 Let-7, lung cancer 1:366-367 lethal giant larvae homolog (Lgl) 2:743, 3:100 lethal toxin (LT) 3:717 leucine-rich repeat (LRR) 3:28, 3:300, 3:391, 3:394, 3:520, 3:712 leucine-rich repeat and immunoglobulinlike domain1 (LRIG1) 3:795 leucine-rich repeat kinase 2 (LRRK2) 2:385-386, 3:573 leukemia inhibitor factor (LIF) 3:440 leukemic cancer stem cells 3:810 leukocyte adhesion disorders (LAD) 3:754 leukocyte responses to bacteria 4:98 leukocyte tyrosine kinase (LTK) 3:16 leukocytes 4:82 LeuLeuOMe dipeptidyl ester 1:615 Lewis X (LeX) 2:342 Lewy body dementia 1:768, 1:773 LeX see Lewis X (LeX) LFA-1 see lymphocyte function-associated antigen-1 (LFA-1) Lgl see lethal giant larvae homolog (Lgl) LGMD2A see limb-girdle muscular dystrophy type 2A (LGMD2A) LGP2 see laboratory of genetics and physiology 2 (LGP2) LHX2 see LIM homeobox protein 2 (LHX2) library preparation 1:31-32 LIC see light-intermediate chains (LIC) LIF see leukemia inhibitor factor (LIF) life sciences, FLIM applications in autofluorescence FLIM 2:110 FRET experiments 2:109-110 local molecular environment parameters measurement 2:108-109 Life Technologies 1:64 lifetime line broadening 1:104-105 LIG4 see Ligase IV (LIG4) ligand-gated ion channels 1emitting diodes (LEDs) 2:149 light microscopy (LM) 2:168 light sheet fluorescence microscopy (LSFM) 2:55 light-dependent reactions 2:328 light-emitting diodes (LEDs) 4:238-239 light-gated glutamate receptor (LiGluR) 2:151 applications 2:153 principles 2:151-153 light-intermediate chains (LIC) 2:620 light-sensitive proteins 2:148T LiGluR see light-gated glutamate receptor (LiGluR) LIM homeobox protein 2 (LHX2) 3:794-795 limb-girdle muscular dystrophy type 2A (LGMD2A) 1:676 limit-dextrinase (LDA) 1:267-268 LIMK see LIM kinase (LIMK) LIMPs see lysosomal integral membrane proteins (LIMPs) Lin-7 homolog C (Lin-7C) 3:102 Lin12/Notch repeats (LNR) 3:107 LINC see linker of nucleoskeleton and cytoskeleton (LINC) lineage-committed cells (LCCs) 3:801 linear kinetics 4:29 linear ubiquitin chain assembly complex (LUBAC) 3:357-358 linker of activated T cells (LAT) 3:680 linker of nucleoskeleton and cytoskeleton (LINC) 2:315, 2:573 lipases 1:257, 1:615-616 lipid asymmetry 1:209, 1:210, 1:212, 1:214 lipid bilayers, physical states of lipids in 1:208",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "monocytogenes (L. monocytogenes) 2:785 Listeria toxin (LLO) 2:287 listeriolysin O (LLO) 2:780, 2:790, 3:597 live animals imaging individual cells in 2:139F imaging tissue architecture and function in 2:134-135F tumor progression and invasive behavior in 2:137-138F live cell/living cells 1:5 compatibility 2:113-114 images 2:65 imaging 2:56-59 laws of thermodynamics and 1:5-6 molecular crowding effect in 1:11-12 live cell imaging 2:70 live SIM 2:94-95 live-cell imaging techniques 4:222 liver 1:237 liver kinase B1 (LKB1) 3:102, 3:130 liver pyruvate kinase 1:292-293 liver sinusoidal endothelial cell (LSEC) 3:641, 3:641 liver X-receptors (LXR) 1:176-177 LXRa 2:427 LXRb 2:427 LKB1 see liver kinase B1 (LKB1) see lysosomal membrane permeabilization (LMP) LMTK2 see Lemur tyrosine kinase 2 (LMTK2) LMWK see low-molecular weight kininogen (LMWK) LN see lymph node (LN) LN 2 see liquid nitrogen (LN 2 ) LNAs see locked nucleic acids (LNAs) lncRNAs see long noncoding RNAs (lncRNAs) LNR see Lin12/Notch repeats (LNR) Loa see Legs at odd angles (Loa) lobopodial migration 3:212 local excitation, global inhibition mechanism (LEGI mechanism) fluorescent probes in 2:122T future trends/avenues 2:126-127 high-speed 2:123-124 localization concept 2:121-122 sequence flow in live cell 2:122F locked nucleic acids (LNAs) 1:368 Loeys-Dietz syndrome (LDS) 3:46-47 Log P 1:135, 1:138 logarithmic gain 4:44, 4:45, 4:46 London resin (LR) 2:34 long noncoding RNAs (lncRNAs) 1:364, 1:369-370, 4:160 long range inhibitor 4:52 longin v-SNAREs Sec22b 2:461-463 long-loop recycling pathway 2:401 long-term depression (LTD) 2:535 long-term potentiation (LTP) 2:401, 2:535 5 0 long terminal repeat (LTR) 2:835 loops 1:112 lopinavir 1:743 loss of function 1:514 low dead volume sampling device 4:203F low degree of separation 4:68 low density lipoprotein receptor class A (LDLA) 1:655 low density lipoprotein-receptor class A-like domain (LDLRA domain) 1:650, 1:729 Low pH 2:219 low-density granulocytes (LDGs) 3:753-754 low-density lipoprotein (LDL) 1:173-174, 2:176, 2:205-206, 3:13, 3:418, see lysyl oxidase (LOX) LOXL2 see LOX-like 2 (LOXL2) LOX-like 2 (LOXL2) 4:143 LPA acytransferase type g (LPAAT-g) 2:360 LPA see lysophosphatidic acid (LPA) LPAM-1 see lymphocyte Peyer's patch adhesion molecule (LPAM-1) LPLA 2 see lysosomal phospholipase A 2 (LPLA 2 ) LPS see lipopolysaccharide (LPS) LR see London resin (LR) LRCs see label-retaining cells (LRCs) LRIG1 see leucine-rich repeats andimmunoglobulin-likedomain1 (LRIG1) LROs see lysosome-related organelles (LROs) LRP see LDL-receptor-related protein (LRP) LRP5/6, Frizzled and 3:87-88, 3:88F LRR see leucine-rich repeat (LRR) LRRK2 see leucine-rich repeat kinase 2 (LRRK2) LS see least squares (LS) LSDs see lysosomal storage diseases (LSDs) LSEC see liver sinusoidal endothelial cell (LSEC) LSFM see light sheet fluorescence microscopy (LSFM) LT see lethal toxin (LT); lymphoid tissues (LT); lymphotoxin (LT) LTA see lipoteichoic acid (LTA) LTD see long-term depression (LTD) LTi cells see lymphoid tissue inducer cells (LTi cells) LTK see leukocyte tyrosine kinase (LTK) LTP see long-term potentiation (LTP) LTPs see lipid transfer proteins (LTPs) LTR see 5 0 long terminal repeat (LTR) LTa see lymphotoxin-a (LTa) LTb see lymphotoxin-beta (LTb) LTbR signaling see lymphotoxin beta receptor signaling (LTbR signaling) LUBAC see linear ubiquitin chain assembly complex (LUBAC) LUCA see last universal common ancestor (LUCA)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF18": {
            "text": "family see mitogen-activated protein kinase kinase family (MAPKK family) MAPKKK see mitogen-activated protein kinase kinase kinase (MAPKKK) MAPKs see MAP kinases (MAPKs) MAPPIT see mammalian protein-protein interaction trap (MAPPIT) MAPs see microtubule-associated proteins (MAPs); mitogen-activated protein (MAP) MARCH5/MITOL mutant 2:288 Marchado-Joseph disease (MJDs) 3:505-506 MARCO see macrophage receptor with collagenous structure (MARCO) Marfan syndrome (MFS) 3:46-47 marginal reticular cells (MRCs) 3:616 marginal zone (MZ) 3:759 apoptotic cells clearance 3:763 MARINa see Master Regulator Inference algorithm (MARINa) Markov chain Monte Carlo 4:212T, 4:214 Maroteaux-Lamy disease (MPS VI) 1:777, 1:782 marrow-isolated adult multilineage inducible cells (MIAMI cells) 3:819 Mas receptor 1:747 Mash 3:790-791 Maskless array synthesis 1:47 Mason-Pfizer monkey virus (M-PMV) 1:744 MASPs see MBL-associated serine proteases (MASPs) mass spectrometry (MS) nodes of proteome 4:170 organization of proteome 4:170-171 chromatography in combination with 1:151 peptide and protein sequences 1:79 proteomic measurements 1:79-80 technologies 4:163 mass-balance 4:24-25, 4:25F equation 4:25 massively parallel DNA sequencing 1:32 mast cells 2:226-227 master regulator genes (MR genes) 4:259 Master Regulator Inference algorithm (MARINa) 4:259, 4:260F MAT see mesenchymal-amoeboid transition (MAT) cell-ECM and cell-cell adhesion molecules 1:625 cytokines and chemokines and their receptors 1:624-625 ECM 1:624 intracellular activities 1:625 therapeutic targets and anti-targets 1:627 matrix protein (MA protein) 2:828-829 matrix-assisted laser desorption ionization (MALDI) 1:79 Mats see Mob as tumor suppressor (Mats) maturation promoting factor (MPF) 3:424, 3:427-428, 3:427F mature neutrophils 3:751 MAVS see mitochondrial antiviral-signaling protein (MAVS) MAVS protein see mitochondrial antiviral signaling protein (MAVS protein) MaxCyte STX s 1:61-62 maximal connectivity centers 2:456-457 maximum likelihood (ML) 4:257 MB see microtubule blades (MB) MBD1 3:790-791 MBL see mannose-binding lectin (MBL) MBL-associated serine proteases (MASPs) 1:726 MASP-1 1:727 MASP-2 1:727 MASP-3 1:727-728 MASP1/3 gene 1:726 MBP see maltose-binding protein (MBP); myelin basic protein (MBP) MC see mother centriole (MC) MCAK see mitotic centromere-associated kinesin (MCAK) MCC see mitotic checkpoint complex (MCC) MCF see methylchloroformate (MCF) MCL1 see myeloid cell leukemia sequence 1 (MCL1) MCM see mini-chromosome maintenance (MCM) MCM proteins see mini-chromosome maintenance proteins (MCM proteins) MCP-1 see monocyte chemoattractant protein 1 (MCP-1) MCS see membrane contact sites (MCS) M-CSF see macrophage-colony-stimulating factor (M-CSF) MCT see mono-carboxylate transporter (MCT) MCUs see mitochondrial calcium uniporters (MCUs) MDA5 see melanoma differentiation factor 5 (MDA5) MDCK cells see Madin-Darby canine kidney cells (MDCK cells) mDCs see migratory DCs (mDCs) MDGI see mammary-derived growth inhibitor (MDGI) mDia1 see mammalian Diaphanous 1 (mDia1) Mdm2 see mouse double minute 2 (Mdm2) MDM2 binding ribosomal proteins 3:285-286 MDM2 see mouse double minute 2 (Mdm2); murine double minute 2 (MDM2) MDM2-p53 pathway, non-ribosomal functions of RPs independent of 3:283 Mdm10 2:281-282 Mdm12 2:281-282 Mdm34 2:281-282 MDP see macrophage-DC progenitors (MDP); muramyl dipeptide (MDP) MDR see multidrug resistance (MDR) MDS see myelodysplastic syndrome (MDS) MDVs see mitochondria-derived vesicles (MDVs) ME see malic enzyme (ME) mean field theory 4:83 mean square displacement (MSD) 2:124-125, 2:126 MEB see muscle-eye-brain disease (MEB) mechanical forces 2:724 mechanical induction 2:629 mechanistic target of rapamycin (mTOR) 3:815 mechanistic target of rapamycin complex (mTORC) 1:765 mTORC1 1:765, 1:765-766, 1:766, 1:766-767, 1:771 mechanochemical ATPase cycle 2:601 mechanoreceptors, TCR as 3:655 mechanosensing 2:716-717 mechanosensory organs 3:199 mechanotaxis 3IAP (ML-IAP) 1:707-708, 3:394 melanophilin see Slac2-a melanosomes 2:228, 2:235 molecular basis 2:236-237 MELAS see mitochondrial myopathy, encephalopathy, lactic acid acidosis, and stroke like episodes (MELAS) MELT see Met-Glu-Leu-Thr (MELT) membrane asymmetry 1:205, 1:206 membrane contact sites (MCS) 2:461-462 membrane fusion 2:485, 2:833, 3:498-499 nanomachines 2:459-460 core mechanism 2:460F regulators 2:460-461 membrane potential (V m ) 1:218-236, 1:218, 1:244, 1:244-245, 1:247, 1:248 caveats in measuring physiological V m 1:232-234 definitions of different types of 1:218 determinants of 1:221-223 active ion transport 1:226 changes in ion concentrations 1:225-226 electrochemical driving force for ion movement 1:221-223 ion channel gating 1:229 passive ion transport via selective 1:226-229 passive membrane potential changes 1:229-230 relative membrane permeability 1:223-225 steady state vs. electrochemical equilibrium 1:225 membrane selectivity and direct measurements of 1:230-231 physiological values of 1:234-235 quantifying membrane and ion channel selectivity 1:231-232 membrane protein interaction with rafts 1:209-210 membrane protrusions 2:790 membrane rafts see lipid rafts membrane-based adenosine triphosphate synthesis, energetics of 1:298 membrane-bound fluorescent probes 1:213 membrane-bound phagosome formation 2:776 membrane-bound TNF (mTNF) 3:62-63 membrane-bound a-glucosidase (MOGS) 2:341 membrane-cytosol interface, phosphoinositides at 2:505 stromal cells (MSCs) see multipotent stromal cells (MSCs) mesenchymal-amoeboid transition (MAT) 3:226 mesoderm development (MESD) 2:420-421 mesoscale systems biology 4:51-55 message-passing approach 4:212T, 4:215-216",
            "latex": null,
            "type": "figure"
        },
        "FIGREF19": {
            "text": "substrates (fuel) availability 1:289 transcriptional and degradational control 1:290 metabolic reprogramming 3:789-790 metabolic stress response, nucleolar signaling networks in 3MetaHIT see metagenomics for human intestinal tract (MetaHIT) metal binding sites 1:123 metal ions 1:19 metallo 1:753 metallophilic macrophages 3:761-762 metalloproteases 1:19, 1:562 ADAM and AMAMTS proteases 1:754-755 matrix metalloproteinases 1:755-756 metamyelocyte 3trains 2:723 MF see metformin (MF); molecular function (MF); myelofibrosis (MF) Mff see mitochondrial fission factor (Mff) MFG-E8 see milk fat globule-epidermal growth factor-like 8 (MFG-E8) Mfn1 2:279-281 mitochondrial fusion 2:288-289 Mfn2 2:279-281 mitochondrial fusion 2:288-289 MFS see Marfan syndrome (MFS) MFs see microfilaments (MFs) MGDG see monogalactosyldiglyceride (MGDG) mGluRs see metabotropic glutamate receptors (mGluRs) MH1 domain see Mad Homology 1 domain (MH1 domain) MH2 see C-terminal mad homology 2 (MH2) MHC class II 3:6, 3:588, 3:594 MHC see major histocompatibility complex (MHC) MHC-II compartment (MIIC) 3:590 MHV see mouse hepatitis virus (MHV) MI see mutual information (MI) MIAME see minimum information about micro-array experiment (MIAME) MIAMI cells see marrow-isolated adult multilineage inducible cells (MIAMI cells) MIB see mitofusin binding protein (MIB) Michael acceptor function 1:131 Michaelis-Menten kinetics 1:14-15, 1:15 Michaelis-Menten model 1:8-9 microarray 4:160, 4light-emitting diode-mediated DNA synthesis in glass capillaries 1:50 microhomology-mediated end joining (MMEJ) 1:452, 1:461 microparticle (MP) 1:716 micropinocytosis 2:4 micropinosomes 2:758 microprocessor complex 1:354, 1microtubule dynamics and 4:38-40 functions in cells 2:542FMAP1b 3:237-238 role in mitotic spindle assembly 2:639 microtubule-based motors 22:640 microvesicles 2:738 microvillus inclusion disease 2:192 Mid49 2:284-285 see also mitochondrial dynamics protein of 49 missense polymorphism 1:700 missing pyramid 2:24-25, 2:25-26 missing wedge 2:24-25, 2:25-26 missing-in-metastasis (MIM) 2:497 MIT motifs see microtubule-interacting and transport motifs (MIT motifs) aaRS in human disease 1:547-548 aminoacylation of 1:547 genetic code in mitochondria 1:546 and human diseases 1:333-334 import of tRNAs 1:546 structural features of 1:546-547 structure of 1:316F mitochondrial b-oxidation 2:252 mitochondrial-associated membranes 2:531-532 mitochondrial-nuclear interactions 1cell cycle 3:478F as anticancer drug target 3:486 cell fates 3:400F centromere-kinetochore association 3:481F CPC during 3:470-471 NE disassembly and reassembly closed mitosis 2:315 disassembly and reassembly 2:317 importin a/b and Ran system 2:316F open mitosis 2:315 RanGTP gradient 2:315-317 regulation of mitotic exit 3:401F stages 3:479F anaphase 3:481 cytokinesis 3:481-484 metaphase 3:480-481 prometaphase 3:480 prophase 3:479-480 telophase 3:481 targeted antimitotic compounds 3:487-489T unscheduled entry into 3:399of spindle assembly 2:638-639 properties 2:640 microtubule turnover 2:640 poleward microtubule flux 2:640-641 spindle length control 2:641 visco-elastic nature 2:641 role of motors and MAPs in mitotic spindle assembly 2:639 microtubule cross-linkers 2:639 microtubule depolymerizationpromoting proteins 2:640 microtubule polymerization-promoting proteins 2:639-640 MIWI see murine PIWI protein (MIWI) mixed lineage kinase domain-like (MLKL) 3:342, 3:393-394 MJDs see Marchado-Joseph disease (MJDs) MKK4 3:123F, 3:124 MKK7 3:123F, 3:124 MKLP1 see mitotic kinesin-like protein-1 (MKLP1)MKP6 3:125 MKS see Meckel-Gruber Syndrome (MKS) ML see maximum likelihood (ML) MLC see myosin light chain (MLC) MLCK see myosin light chain kinase (MLCK) ML-IAP see melanoma IAP (ML-IAP) MLKL see mixed lineage kinase domain-like (MLKL) Mll1 (mixed lineage leukemia 1) 3:790-791 MLN-4760 1:749 mLST8 see mammalian Lethal-with-Sec-Thirteen 8 (mLST8) MM see metastatic melanoma (MM) Mm-Cpn 2:8F, 2:9, 2:11, 2:11-12, 2:11F MMEJ see microhomology-mediated end joining (MMEJ) MMLV see Moloney murine leukemia virus (MMLV) Mmm1 2:281-282 MMP see matrixmetalloproteinase (MMP) see macrophage mannose receptor (MMR); mismatch repair (MMR) MMTV see mouse mammary tumor virus promoter (MMTV) MNDA see myeloid cell nuclear differentiation antigen (MNDA) Mob as tumor suppressor (Mats) 3:99 mobile enhancer 1:489 mobile genetic elements 1:377-380, 1:382 ribozyme as 1:380 mobilization, CXCL12 in HSC and HPC 3:626-627 mo-DCs see monocytes DCs (mo-DCs) model simulations 4:72 model-based approaches 4:255-256 modeling 4:72 multiscale see multiscale modeling modeling single-cell transcriptomic data for filopodial protrusion 2:687-688, 2:687F actin cytoskeleton 2:687-688 membrane deformation 2:688 lamellipodia 2:690F, 2cell behavior 4:122-123 mathematical models for studying collective cell behavior 4:123 cell-ECM interactions, modeling 4:125 continuum models 4:123 discrete models 4:123-124 vertical integration 4:122 differential-adhesion driven cell sorting 4:126-127 multiscale modeling of somitogenesis 4:128 regulation of root growth by auxin in Arabidopsis thaliana 4:128-131 studies, examples of 4:125-127 vasculogenesis and angiogenesis 4:127-128 morphology 2:761 Morquio disease 1:782 mosaic serine protease large-form (MSPL) hepatitis virus (MHV) 2:169 mouse knockout studies (KO studies) 2:279-281 mouse mammary tumor virus promoter (MMTV) 3:447 mouse models 1:641-642, 3:438 MP see microparticle (MP) MP1 see MEK1 partner (MP1) Mpdz see multiple PDZ domain protein (Mpdz) MPF see maturation promoting factor (MPF) MPM see multiphoton microscopy (MPM) M-PMV see Mason-Pfizer monkey virus (M-PMV) MPN see myeloproliferative neoplasms (MPN) MPO see myeloperoxidase (MPO) MPP see mitochondrial processing peptidase (MPP) MPR see Man-6-P receptor (MPR); mannose-6-phosphate receptor (MPRs/M6PR) MPS see mucopolysaccharidosis (MPS) MPS VI see Maroteaux-Lamy disease (MPS VI) Mps1 see monopolar spindle 1 (Mps1) MPS1 see multipolar spindle-1 (MPS1) MPS6 (Maroteaux-Lamy disease) 1:782 MPT see mitochondrial permeability transition (MPT) MR see midbody ring (MR) MR genes see master regulator genes (MR genes) MRCs see marginal reticular cells (MRCs) Mreb filaments 2:93-94 MRH domains see Man-6-P receptor homology domains (MRH domains) MRI see magnetic resonance imaging (MRI) MRM see multiple reaction monitoring (MRM) mRNA see messenger RNA (mRNA) MS see mass spectrometry (MS)MSA see multi-stage-activation (MSA); multiple sequence alignments (MSAs) MSCs see mesenchymal stem cells (MSCs); multipotent stromal cells (MSCs) MSD see mean square displacement (MSD) MSMs see medullary sinus macrophages (MSMs) MSPCs see mesenchymal stem and progenitor cells (MSPCs) MSPL see mosaic serine protease large-form (MSPL) MSSE see multiple self-healing squamous epithelioma (MSSE) MSTFA see N-Methyl-Ntrimethylsilylfluoroacetamide (MSTFA) MT see membrane type (MT) MT1-MMP see membrane-type 1 matrix metalloprotease (MT1-MMP) MTAs see microtubule-targeting agents (MTAs) Mtb see Mycobacterium tuberculosis (M. tuberculosis) MTBD see MT-binding domain (MTBD) MT-binding domain (MTBD) 2:620 MTCs see multisubunit tethering complexes (MTCs) MTD see microtubule doublets (MTD) mtDNA see mitochondrial DNA (mtDNA) MTE see motif ten element (MTE) mTEC see medullary thymic epithelial cells (mTEC) Mtl see mannitol (Mtl) MTM1 see myotubularin (MTM1) MTMR1-14 see myotubularin-related proteins 1-14 (MTMR1-14) mTNF see membrane-bound TNF (mTNF) MTOC see microtubule organizing center (MTOC); microtubule-organizing center (MTOC) mTOR see mammalian target of rapamycin (mTOR) also single-cell migration multicolor fluorescence microscopy 2:83 multicolor imaging 2:64 multidimensional TCSPC, time-domain FLIM by 2:114-115 multidrug resistance (MDR) 1:744 multilineage differentiating stress enduring cells (MUSE cells) 3:819 multinodular goiter 1:360 multi-organelle interactions 2:780 multiphoton excitation 2:129 multiphoton microscopy (MPM) 2:129 multiple functions of Gag 2:831F multiple patch cloning (MUPAC) 1:122 multiple PDZ domain protein (Mpdz) 3:102 multiple reaction monitoring (MRM) 1:150, 4:168 multiple regulatory proteins 2:677 multiple sclerosis (MS) 2:728-729, 3:642 multiple self-healing squamous epithelioma (MSSE) 3:47 multiple sequence alignments (MSAs) 3:61 multiple signal pathways, DRs signaling and 3:69 extrinsic apoptotic pathway 3:69 intrinsic apoptotic pathway 3:69-70 non-apoptotic pathways 3:70 multiple sulfatase deficiency 1:774 multiple time and spatial scales in cellular biology 4:72-73 multipolar spindle-1 (MPS1) 3:482 multipotent adult progenitor cells (MAPC) 3:819 multipotent stromal cells (MSCs) 3:780 see also hematopoietic stem cells (HSCs) age-related changes in 3:780 multiscale modeling 4:72, 4:73F, 4:75-76, 4:75, 4:80-85, 4:80, 4:81 adaptive combined cell-based and continuum approach 4see multiple patch cloning (MUPAC) mural cells 4:104 muramyl dipeptide (MDP) 3:717 murine double minute 2 (MDM2) 3:130 murine duodenum epithelium imaging 2:47 murine embryonic fibroblast (MEF) 2:289 murine PIWI protein (MIWI) 3:322 muscle contraction 2:677, 2:677-679 calcium release from SR 2:679-681 sarcomeres 2:677 muscle disorders 2:681 muscle fibers 1:221, 1:224-225, 2:4 muscle satellite cells 3:6-7 muscle stem cells 2:677 extrinsic factors 3:778-779 intrinsic modifications in aged satellite cells 3:779-780 loss of skeletal muscle regenerative potential during aging 3:778 muscle-eye-brain disease (MEB) 2:348-349 muscle-specific kinase (MuSK) 3:17 muscular dystrophy 2:681 MUSE cells see multilineage differentiating stress enduring cells (MUSE cells) MuSK see muscle-specific kinase (MuSK) mutations 4:214 mutations in gene encoding MPO 3-6 2:603 class-7 2:603 class-8 2:603-604 class-9 2:602 class-10 2:603 class-11 2:603-FERM see myosin tail homology 4/ band 4.1, ezrin, radixin, and moesin (MyTH-FERM) MZ see marginal zone (MZ) N N nucleotides see nucleotide nucleotides (N nucleotides) NA see numerical aperture (NA) NAC see N-acetyl cysteine (NAC) N-acetyl cysteine (NAC) 3:816 N-acetyl hexosamines 1:128-130 N-acetylation 1:86 N-acetylgalactosamine (GalNAc) NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) 2:523-524 N-acyl-D-amino acid amidohydrolase 1:125 NAD\u00fe/NADH ratio 1:288, 1:296 NADH see nicotinamide adenine dinucleotide (NADH) NADPH see nicotinamide adenine dinucleotide phosphate (NADPH) NADPH oxidase 3:6 NADPH oxidase see nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) NADP-malate dehydrogenase 1:294 NAFLD see nonalcoholic fatty liver disease (NAFLD) NAGPA see N-acetylglucosaminidase (NAGPA) NAIC see North American Indian childhood cirrhosis (NAIC) with pro-MMPs 1:712 mechanism of inhibition of MMPs 1:711-712 structures 1:711 N-BAR domains see amphipathic N-terminal helix domains (N-BAR domains) NBD see nucleotide-binding domain (NBD) NBEAL2 2:230 NC protein see nucleocapsid protein (NC protein) NC1 domain see non-collagenous 1 domain (NC1 domain) N-cadherin 2:704-705 NCAM see neural cell adhesion molecule (NCAM) NCE see non-clathrin endocytosis (NCE) NCF3 see Rac NCL2 see neuronal lipofuscinosis Type 2 (NCL2) NCLDV see nucleo-cytoplasmic large DNA viruses (NCLDV) NCR see nonconserved region (NCR) ncRNA see noncoding RNAs (ncRNA) NCS-1 see neuronal calcium sensor-1 (NCS-1) NDR see nuclear Dbf-2-related (NDR) NE see nuclear envelope (NE) NE breakdown (NEBD) 2:315 near surface swimming model 2:787 near-infrared (NIR light) 2:129 NEB see nuclear envelope breakdown (NEB) NEBD see NE breakdown (NEBD) NEC see necrotizing enterocolitis (NEC) necroptosis 3:371-372, 3:393-394 necrosis 3:402 mitochondrial control 3:343-345, 3:346F necrotizing enterocolitis (NEC) 2:804 nectins 2:742 NEDD8 (neural precursor cell expressed developmentally downregulated-8) 1:584T, 1:587 neddylation 1:708 NEFs see nucleotide exchange factors (NEFs) negative feedback 4:30-31, 4:31, 4:31F, 4:32, 4:32-33, 4:33, 4:33F, 4:66-67 adaptation through regulation 4:7, 4:7F four-step pathway 4:31F loops 4:219 two-step pathway 4:32F negative regulation modules 3:536-538, 3:537F negative regulators exclusion 3:651-653 negative regulatory region (NRR) 3:107 negative regulatory repeats (NRR) 1:644 NEIL glycosylases see endonuclease VIII-like glycosylases (NEIL glycosylases) Neisseria meningitides infections 2:307-308 NEKs see NIMA-related kinases (NEKs) NEM-sensitive factor see N-ethylmaleimidesensitive factor (NEM-sensitive factor) N-end rule 1NEP see neprilysin (NEP) nephronophthisis (NPHP) 2:664 neprilysin (NEP) 1:747 NER see nucleotide excision repair (NER) NER pathway see nuclear excision repair pathway (NER pathway) Nernst equation 1:223, 1:223-224, 1:225, 1:232F nerve cells 2phagosome maturation 2:769F, 2:770-771 in systemic autoimmune diseases 3:755 CXCL12 in 3:627-628 RA 3:755-756 SLE 3:756 vasculitis 3:755 neutrophil-SGD see neutrophil-specific granule deficiency (neutrophil-SGD) neutrophil-specific granule deficiency (neutrophil-SGD) 3:755 never in mitosis gene A (NIMA) 2:667-668 new gene origination 4:154, 4:156 nexin-DRC 2:663 next generation sequencing (NGS) Nezha see calmodulin-regulated spectrinassociated protein 3 (CAMSAP3) NF1 see neurofibromatosis type1 (NF1) NF2 see neurofibromin 2 (NF2) NFAT see nuclear factor of activated T cells (NFAT) NF-E2 see nuclear factor erythroid 2 (NF-E2) NF-E2p45-related factor 2 (NRF2) 2:531 NF-KB oscillations 3:674-675 nfkb1 KO mice 3:581 nfkb2 KO mice 3:581-582 NFTs see neuro fibrillary tangles (NFTs) NFkB see nuclear factor kappa B (NFkB) NF-kB-inducing kinase (NIK) 3:581-582 NG2 glia 3:800 NGAL see neutrophil gelatinase-associated lipocalin (NGAL) NGD see no-go decay (NGD) NGF see nerve growth factor (NGF); neurotrophic growth factor (NGF) N-glycans see N-linked glycans (N-glycans) N-glycosylation 1:126, 1:555, 1:557-558, 1:563 N-glycosylation quality control pathway 1:599-601, 1:600F N-glycosylation site 1:682-683 NGS see next generation sequencing (NGS) NHEJ see nonhomologous end-joining (NHEJ) NHEJ pathway see nonhomologous endjoining pathway (NHEJ pathway) NHL see non-Hodgkin lymphoma (NHL) NHR see neutralized homology repeat (NHR) NIAP see neuronal inhibitor apoptosis protein (NIAP) NICD see Notch intracellular domain (NICD) niche 3:776 nicotinamide adenine dinucleotide (NADH) 2:110, 2:133, 3:341 dehydrogenase 1:304-305, 1:305 nicotinamide adenine dinucleotide phosphate (NADPH) 2:790, 3:519-520 nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) 2:767, 2:776, 3:702, 3:752 active 3:702F assembly and activation 3:705-706 regulation by phosphorylation 3:706 NIDDM see non-insulin-dependent diabetes mellitus (NIDDM) nidogens 2:697, 4:104 Niemann-Pick C (NPC) 2:206 NPC1 2:425 NPC2 2:425 Niemann-Pick disease type C 1:779, 1:780, 1:783 enzyme therapy 1:783 NIH see National Institutes of Health (NIH) NIK see NF-kB-inducing kinase (NIK) NIMA see never in mitosis gene A (NIMA) NIMA-related kinases (NEKs) NIR light see near-infrared (NIR light) nitric oxide (NO) 1:88, 1:700, 1:717, 3:56 nitric oxide synthase (NOS) 3:57, 3:63, 3:617-618 nitrogen assimilation 2:329 nitrosylation 1:87-88 NK cells see natural killer (NK) cells N-kinesins 2:609 NKT cells see natural killer N-linked glycosylation 1:85-86 NLPs see neuropeptide-like proteins (NLPs) NLR family CARD-containing 4 (NLRC4) 3:394 NLR proteins see NOD-like receptor (NLR) proteins NLR see nucleotide-binding oligomerization domain receptor (NLR) NLRs see nucleotide-binding oligomerization domain-like receptors (NLRs) NLRC4 see NLR family CARD-containing 4 (NLRC4) NLRP3 see NACHT, LRR, and PYD domains-containing protein 3 (NLRP3); NOD-like receptor family pyrin domain-containing 3 (NLRP3) NLs see neutral lipids (NLs) NLS see nuclear localization sequences (NLS); nuclear localization signal (NLS) NLSIM see nonlinear structure illumination (NLSIM) NMD see nonsense-mediated decay (NMD); nonsense-mediated mRNA decay (NMD) NMDA see N-methyl-D-aspartate (NMDA) NMDAR see N-methyl-D-aspartic acid receptor (NMDAR) N-methyl-D-aspartate (NMDA) 1:249 N-methyl-D-aspartic acid receptor (NMDAR) 1:675, 2:294 N-Methyl-N-trimethylsilylfluoroacetamide (MSTFA) 4:203-204 NMII see non-muscle myosin II (NMII) NMJ see neuro-muscular junction (NMJ) NMR spectroscopy see nuclear magnetic resonance (NMR) spectroscopy nNOS see neuronal NOS (nNOS) NNRTI see non-nucleoside reverse transcriptase inhibitors (NNRTI) NO see nitric oxide (NO) NOD see nucleotide oligomerization domain (NOD) -like receptor (NLR) proteins 3:368 NOD-like receptor family pyrin domaincontaining 3 (NLRP3) 3:520 NoDS see nucleolar detention signal (NoDS) NOE see nuclear overhauser enhancement (NOE) noggin (NOG) 3:44 no-go decay (NGD) 3:317 substrate choice 3:318 substrate recognition 3:320-321 nomenclature systematization of biological entities 4:247 non steroidal anti-inflammatory drug (NSAID) 1:666, 3:64 nonalcoholic fatty liver disease (NAFLD) 1:157, 2:534 nonalcoholic steatohepatitis (NASH) 1:157 non-amine-containing phospholipids synthesis in bacteria 1:162-164 in eukaryotes 1:166-169 non-apoptotic pathways 3:70 noncancer telomere-related diseases 1:432-433 noncanonical HH signaling 3:79-80 non-clathrin endocytosis (NCE) 2:212 noncoding RNAs (ncRNA) 1:364, 3:788, 4:160, 4:162 ceRNAs 1:369 eRNAs 1:369 lncRNAs 1:369-370 transposons and piRNAs 1:370 noncoding transcription see germline transcription non-collagenous 1 domain (NC1 domain) 2:696-697 nonconserved region (NCR) 1:469-471 noncovalent interactions 1:10-11 noncrossover 1:461, 1:464-465 nongenetic cell-to-cell heterogeneity stochastic analysis cell signaling 4:218-219 cell-to-cell heterogeneity 4:218 connecting heterogeneity at multiple levels 4:223-224 single-cell analysis 4:220-221 stochastic data modeling and analysis 4:222-223 variability in gene expression 4:220 nongeneticheterogeneity 4:218 non-healing ulcers 3:218 nonhematologic cell secretory lysosomes 2:228 non-Hodgkin lymphoma (NHL) 3:110 nonhomologous DNA end joining see nonhomologous end-joining pathway (NHEJ pathway) by ARTEMIS-DNA-PKcs complex 1:451 template-dependent and templateindependent DNA synthesis 1:451 pathway 3:558-560 non-insulin-dependent diabetes mellitus (NIDDM) 1:677 nonlinear structure illumination (NLSIM) 2:95 non-lymphoid organs, DCs in 3:741 non-lymphoid tissue (NLT) DC 3:595 CD103 \u00fe CD11b -DCs 3:595 CD11b \u00fe DCs 3:595 Langerhans cells and migratory DCs 3:595-596 and migratory DCs 3:597 non-motile cilia 2:660-661 axoneme structure 2:663 diseases caused by defective 2:670-671 non-muscle myosin II (NMII) 2:601, 2:602, 2:720 non-nucleoside reverse transcriptase inhibitors (NNRTI) 2:837 non-receptor tyrosine kinases 3:156 non-ribosomal peptide synthetases (NRPS) 1:95 nonribosomal polypeptide synthase 1:14 nonsense-mediated decay (NMD) 3:317 substrate choice 3:317-318 substrate recognition 3:319-320 nonsense-mediated mRNA decay (NMD) 1:351-352 nonstop-decay (NSD) 3:317 substrate choice 3:318-319 substrate recognition 3:321 nonstructural proteins 2:810 nontemplate strand 1:471-472, 1:474 Noonan syndrome (NS) 3:417-418 NoRC see nucleolar remodeling complex (NoRC) Norrin 3:89, 3:89F NORs see nucleolar organizing regions (NORs) North American Indian childhood cirrhosis (NAIC) 3:295 NOS see nitric oxide synthase (NOS) NOS2 see iNOS Notch 4:102, 4:112 Notch-sparing inhibitors 1:665 receptor 1:662 Notch intracellular domain (NICD) 1:643-644, 4:112 Notch pathway 3:2 Notch signaling pathway 3:107, 3:108Fsee also Hippo pathway see nuclear protein (NP) NPC see neural precursor cells (NPCs); Niemann-Pick C (NPC); nuclear pore complex (NPC) NPFs see nucleation promoting factors (NPFs) NPHP see nephronophthisis (NPHP) NpHR see natronomonas pharaonis (NpHR) NPM see nucleophosmin (NPM) NPM1 see nucleophosmin 1 (NPM1) NPxY motifs see Asn-Pro-x-Tyr motifs (NPxY motifs) Nramp2 see SLC11a2 iron transporter Nrf1 1:591 NRF2 see NF-E2p45-related factor 2 (NRF2) NRG1 see neuregulin-1 (NRG1) NRP see neuropilin (NRP) NRPS see non-ribosomal peptide synthetases (NRPS) NRR see negative regulatory region (NRR); negative regulatory repeats (NRR) NRTI see nucleoside reverse transcriptase inhibitors (NRTI) NS see Noonan syndrome (NS) NSAID see non steroidal anti-inflammatory drug (NSAID) NSCs see neural stem cells (NSCs) NSD see nonstop-decay (NSD) NSF see N-ethylmaleimide-sensitive factor (NSF) N-site 4:36, 4:37-38, 4:39F NSUN2 1:334, 1:334-335 NT see neurotrophins (NT) NT domain see nucleotidyl transferase domain (NT domain) NTC see nineteen complex (NTC) NTD see N-terminal domain (NTD) N-terminal 'M13' peptide 2:53-54 N-terminal domain (NTD) 1:468-469 N-terminal fragments (NTFs) 1:664 N-terminal methionine 1:529 N-terminal method 1:75-76 N-termini, negative selection of 1:568, 1:574-575 N-termini, positive selection of 1:568,1:576 NTF2 see nuclear transport factor 2 (NTF2) NTFs see N-terminal fragments (NTFs) NTR see nuclear transport receptor (NTR) NTRK3 see neurotrophic tyrosine kinase, receptor, type 3 (NTRK3) nuclear, chromatin topography 2:91 nuclear aggresomes 2:826 nuclear body 3:261 nuclear Dbf-2-related (NDR) 3:99 nuclear deformability 2:573 nuclear distribution E 2:624 nuclear entry and integration 2:835",
            "latex": null,
            "type": "figure"
        },
        "FIGREF20": {
            "text": "OA see osteoarthritis (OA) OAD see outer-arm dyneins (OAD) OB see olfactory bulb (OB); oligosaccharide binding (OB) OB fold 1:396, 1:407 obesity 2:804-805 objective lens 2:14-15 OBO see open biomedical ontologies (OBO) observation volume 2:101 OCA1 see oculocutaneous albinism type 1 (OCA1) OCA2 see oculocutaneous albinism type 2 (OCA2) Oct4 see octamer-binding protein 4 (Oct4) octamer-binding protein 4 (Oct4) ODAs see outer dynein arms (ODAs) ODE see ordinary differential equation (ODE) ODN see oligodeoxynucleotide (ODN) oep see one-eyed pinhead (oep) OFDI see optical frequency domain imaging (OFDI) O-Fuc glycans see O-linked fucose glycans (O-Fuc glycans) O-fucosylation 1:633 O-Gal glycans see O-galactose glycans (O-Gal glycans) O-galactose glycans (O-Gal glycans) 2:351 O-GalNAc glycans 2:347-348, 2:348F OGG1 see 8-oxoguanine DNA glycosylase (OGG1) O-Glc glycans see O-glucose glycans (O-Glc glycans) O-GlcNAc glycans 2:351 O-GlcNAc transferase (OGT) 1:281 O-GlcNacylation 2:287 O-glucose glycans (O-Glc glycans) 2:350-351 O-glycans 2:3",
            "latex": null,
            "type": "figure"
        },
        "FIGREF21": {
            "text": "p150glued protein 2:476 p300/CBP-associated factor (PCAF) 3:507 PA edematoxin (PA \u00fe EF) 2:795 PA see phosphatidic acid (PA); protective antigen (PA) PA28 1:590 PA200 1:590, 1:591 PAB see poly(A)-binding protein (PAB) Pab1 1:348 PABA-peptide see N-benzoyl-L-tyrosyl-paminobenzoic acid (PABA-peptide) PABP see poly(A) binding protein (PABP) PACs see photo-activated adenylyl cyclases (PACs) PACS1 see phosphofurin acidic cluster sorting protein 1 (PACS1) PACSIN see protein kinase C and casein kinase 2 substrate in neurons (PACSIN) PACT see protein kinase R-activating protein (PACT) PAD4 see peptidylarginine deamininase 4 (PAD4) PA-FP see photoactivatable fluorescent proteins (PA-FP) PAI-1 see plasminogen activator inhibitorPAK see p21-activated kinase (PAK) PAK1 phosphorylates CtBP1/BARS 2:394 Palade lab 2:156 palindromic nucleotides (P nucleotides) 3:559-560 palivizumab 1:145 PALM see photosee peptidylglycine a-amidating monooxygenase (PAM) PAMPs see pathogen associated molecular patterns (PAMPs) PAN2 see poly(A)-nuclease 2 (PAN2) pancreatic enzymes 1:257 pancreatic secretions, in CF patients 1:257, 1:257-259 pancreatic b-cell function 2:533 UPR signaling contributing degeneration 2:533 Pannier production (Pnr production) 4:67 Papillon-Lef\u00e8vre syndrome (PLS) 3:754-755 Par complex 2:742-743 par genes see partitioning defective genes (par genes) PAR1 see protease-activated receptor1 (PAR1) paracellin-1 see Claudin-16 paracrine activity 4:102, 4:104 paracrine signaling 3:672, 3:802-803, 3:809 PARADIGM algorithm 4:216 parallel bundles of actin filaments 2:686 in filopodia 2:683 parallel reaction monitoring (PRM) 4:168 paralogous gene duplications 1:81-82 sequences 1:81 paramagnetic effects 1:100 paramagnetic pseudocontact shift (PCS) 1:98 paramagnetic relaxation enhancement (PRE) 1:98 paramagnetic-based distance restraints 1:99-100 parasitic roundworm (Ascaris megalocephala) 2:649 parathyroid hormone receptor (PTHR) 2:482 PAR-CLIP see photoactivatable ribonucleoside CLIP (PAR-CLIP) parietal cells 1:733 Parkinson's disease (PD) /ParR/parC (ParMRC) 2:592 PARN see poly(A)-specific ribonuclease (PARN) PARP see poly-ADP ribose polymerase (PARP) PARs see protease activated receptors (PARs) parthanatos 3:342, 3see Phox Bem1p (PB1) PBA see 4-phenylbutyric acid (PBA) PBM see protein-binding microarrays (PBM) P-bodies 1:349 PBS see primer binding site (PBS) PC see phosphatidylcholine (PC); plastocyanin (PC) PC12 cells 4:47 response to growth factor stimulation 4:46 PCA see principle component analysis (PCA); protein complementation assay (PCA) PCAF see p300/CBP-associated factor (PCAF) PCAM-1 see platelet-endothelial cell adhesion molecule-1 (PCAM-1) p-carboxymethylphenylalanine (pCMF) 2:523 PCB see polychlorinated biphenyl (PCB) PCBP2 see poly C binding protein 2 (PCBP2) PCC see post-cleavage complex (PCC) PCD see primary ciliary dyskinesia (PCD); programmed cell death (PCD) PC-FPs see photoconvertible fluorescent proteins (PC-FPs) PcG see polycomb group genes (PcG) PCH see photon count histogram (PCH) pcIC see pericentrosomal IC (pcIC) PCM see pericentriolar material (PCM) pCMF see p-carboxymethylphenylalanine (pCMF) PCNA see proliferating cell nuclear antigen (PCNA) PCP see planar cell polarity (PCP) PC-PLC see phosphatidylcholine phospholipase C (PC-PLC) PCR see polymerase chain reaction (PCR) PCS see paramagnetic pseudocontact shift (PCS); pseudocontact shifts (PCSs) PCSK9 see proprotein convertase subtilisin/ kexin type 9 (PCSK9) PCST methods see Prize-collecting Steiner Tree methods (PCST methods) PCST see Prize-collecting Steiner Tree (PCST) PCV see pathogen-containing vacuoles (PCV); polycythemia vera (PCV) PD see Parkinson's disease (PD) PDB see Protein Data Bank (PDB) PDC see pyruvate dehydrogenase complex (PDC) pDCs see plasmacytoid dendritic cells (pDCs) PDEs see partial differential equations (PDEs); phosphodiesterases (PDEs) PDGF receptor beta (PDGFRB) 3:434 PDGF see platelet-derived growth factor (PDGF) PDGFA see platelet-derived growth factor A (PDGFA) PDGFRB see PDGF receptor beta (PDGFRB) PDGFRs see platelet-derived growth factor receptors (PDGFRs) PDGFRb see platelet-derived growth factor receptor b (PDGFRb) PDH see pyruvate dehydrogenase (PDH) PDI see protein disulphide isomerase (PDI); protein-DNA interaction (PDI) PDK1 see phosphoinositide-dependent kinase 1 (PDK1) PDKs see pyruvate dehydrogenase kinases (PDKs) pdMS 3 see phosphorylation directed MS 3 (pdMS 3 ) 3-PDPK1 see 3-phosphoinositide dependent protein kinase 1 (3-PDPK1) PDZ domain see PSD95, Dlg1 and zo-1 domain (PDZ domain) PE see phosphatidylethanolamine (PE); pulmonary embolism (PE) 1PE see single photon excitation (1PE) 2PE see two-photon excitation (2PE) PEF(L) domain see penta-EF-hand large domain (PEF(L) domain)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF22": {
            "text": "see pore membrane proteins (Poms) POMT1 see protein O-mannosyltransferase 1 (POMT1) POP3 see pyrin domain only protein 3 (POP3) porcupine (Porc) 3:87, 3:87F pore membrane proteins (Poms) 3:175 pore-forming toxins (PFTs) 2:776, 2:794, 2:846 positive feedback 4:31, 4:67 signal amplification through 4:8 positive reference set (PRS) 4:188 positive selection 4:156 positive-transcriptional elongation factor b (P-TEF-b) 2:835 positron emission tomography (PET) 1:143 post synaptic receptors 1:248-249 post-cleavage complex (PCC) 3:558 post-embedding labeling see on-section labeling post-Golgi transport 2:363-370 see also intra-Golgi transport constitutive transport via endosomal hubs 2:364-365 lipid rafts in sorting and transport 2:365-366 modulating constitutive transport 2:363-364 in polarized cells 2:364F polarized transport 2:364 TGN-derived constitutive transport 2:363 TGN cargo sorting and packaging at 2:365-366 protein-based sorting in 2:366 tubules and carriers 2:366-367 postpartum breast cancer 3:376 postsynaptic density (PSD) 2:294 postsynaptic response 1:248 posttranscriptional control 3:553-554 posttranslational modification and enzyme activity 1:290 posttranslational modifications (PTMs) 1:22-23, 1:75, 1:84, 1:507, 1:557-558, 1:563, 2:176, 2:294, 2:573-574, 2:617, 3:719, 3:722-723, see protein phosphatase (PP) PP1 see protein phosphatase 1 (PP1) 5'-ppp see 5' triphosphate (5'-ppp) PP2A see Protein phosphatase 2A (PP2A) PPARs see peroxisome proliferator-activated receptors (PPARs) ppGpp small molecule effector 1:468-469 PPIases see peptidylprolyl isomerases (PPIases) PPIF see peptidylprolyl isomerase F (PPIF) PPII see poly-proline type II (PPII) PPIs see protein-protein interactions (PPIs) p-pol incident light 2:63-64 PPP see pentose phosphate pathway (PPP) PPPSPxS 3:91, 3:91F, 3:92, 3:93F PQ see plastoquinone (PQ) PQD see pulsed Q-dissociation (PQD) pQTL analysis see protein quantitiative trait loci analysis (pQTL analysis) PR see protease (PR); retroviral protease (PR) PR3 see proteinase 3 (PR3) PRAS40 see proline-rich Akt substrate of 40 kDa (PRAS40) pRb see retinoblastoma protein (pRb) PRC see Polycomb repressive complex (PRC) PRC1 see polycomb repressive complexes 1 (PRC1); protein regulator of cytokinesis-1 (PRC1) PRC2 see polycomb repressive complex 2 (PRC2) PRD see C-terminal proline-arginine domain (PRD); proline-rich domain (PRD) PRE see paramagnetic relaxation enhancement (PRE)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF23": {
            "text": "therapeutic targets 3:736 SCBC see single-cell barcode chip (SCBC) SCC see squamous cell carcinoma cells (SCC) SCD see stearoyl desaturase (SCD) SCDO see spondylocostal dysostosis (SCDO) SCF see stem cell factor (SCF) scFv see single-chain Fv (scFv) SCG10 see super cervical ganglion clone 10 (SCG10) Schizosaccharomyces pombe polarity regulation 4:54 Schnaitman's approach 1:237 Schwann cells 1:247-248 SCID see severe combined immunodeficiency (SCID) SCIN see staphylococcal complement inhibitor (SCIN) sCJD see sporadic CJD (sCJD) SCMs see subcapsular macrophages (SCMs) SCN see severe congenital neutropenia (SCN) SCNT see somatic cell nuclear transfer (SCNT) SCOP see structural classification of proteins (SCOP) scrapie 2:839 screening 4:264, 4:264-265 Scribble (Scrib) 2:743, 3:100 SCs see stem cells (SCs) SCS see subcapsular sinus (SCS) SCV see Salmonella-containing vacuole (SCV) SCX see strong cation exchange (SCX) Sd see Scalloped (Sd) SD sequence see Shine-Dalgarno (SD) sequence SDM see Site-directed mutagenesis (SDM) sdRNA see snoRNA-derived RNA (sdRNA) SDSA pathway see synthesis-dependent strand annealing pathway (SDSA pathway) SDS-PAGE see sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) SE see sterol esters (SE) sea urchin sperm protein 1:650 seam 2:539, 2:539framework 2:373-374 constitutive secretion 2:371 control system balances 2:374F extent of regulation network 2:371-372 Golgi-based signal molecules 2:372F interaction with reticulum 2:779-780 manipulation to support bacterial replication 2:778-779 regulated secretion 2:371 regulation 2:371 signaling pathways 2:373 traffic regulation 2:372-373 secretory protein biogenesis of 1:535-544 continuation of productive journey 1:601-602 N-glycosylation quality control pathway 1:599-601, 1:600F perilous journey 1:597-599 translocation, folding, and ER exit of 1also targeted data acquisition selective 2 0 -hydroxyl acylation analyzed by primer extension (SHAPE) 1:27 selective monofunctional uracil-DNA glycosylase (SMUG1) 1:444 selective serotonin reuptake inhibitors (SSRIs) 1:248 selenocysteine (Sec) 1:526 SELEX see systematic evolution of ligands by exponential enrichment (SELEX) self-eating see autophagy self-enhancement 3:202, 3:202-203 self-labeling proteins 2:83-84 self-renewal 3:813, 3:814 self-similar 4:59 self-splicing introns 1:22 self-tolerance, establishing 3:605 central tolerance 3:605 peripheral tolerance 3:605-606 regulatory T cells (Tregs) 3:606-607 role of CD28 3:606 Seliciclib 4:99 SEM see scanning electron microscopy (SEM) Sema3 see semaphorin class 3 in comparison to actin microfilaments, microtubules and intermediate filaments 2:580T diffusion barrier 2:581 filaments 2:580, 2:581 assembly 2:579F see smooth endoplasmic reticulum (SER) Ser/Thr see serine/threonine (Ser/Thr) SERCA see sarco-endoplasmic reticulum Ca 2 \u00fe ATPase (SERCA) Ser-Gln/Thr-Gln rich domain (SQ/TQ rich domain) 3:461-462 serglycin 1:271, 1:274-275 serial analysis of gene expression (SAGE) 4:160 serial block face imaging 2:18 serial block face scanning electron microscopy (SBF-SEM) 2:44, 2:45F, 2:46 serial section scanning electron microscopy (ssSEM) 2:44 serine palmitoyltransferase (SPT) 1:183-184 serine protease domains (SPD) 1:650 serine protease inhibitors (serpins) activation system 1:756 serine/threonine (Ser/Thr) 3:781 Serine-Arginine rich (SR) proteins 1:506 serinopathy 1:706 serpin G1 see C1-inhibitor serpins 3:332 serpins see serine protease inhibitors (serpins) serrate 1:360, 2:350 Sertoli-Leydig cell tumor 1:360 serum and glucocorticoid-activated kinase (SGK) 3:124 severe acute respiratory syndrome (SARS) see starch excess (SEX) sex-chromosome 4:156 Sex-determining region Y (SRY) 3:104 sex-determining region Y-box 9 (SOX9) 3:794-795 SFC see supercritical fluid chromatography (SFC) SFD see Sorsby fundus dystrophy (SFD) sFI see sporadic fatal insomnia (sFI) SFK see Src-family kinases (SFK); Src family of tyrosine kinases (SFKs) sFlt1 see splice variants of VEGFR1 (sVEGFR1) sFRPs see secreted Frizzled-related proteins (sFRPs) SFV see Semliki Forest virus (SFV) SG see specific granules (SG) sGCs see soluble GCs (sGCs) SGK see glucocorticoid-stimulated kinase (SGK); serum and glucocorticoidactivated kinase (SGK) SGs see stress granules (SGs) SGZ see subgranular zone (SGZ) SH see src homology (SH) SH1 see SRC homology region 1 (SH1) SH2 see Src homology 2 (SH2) SH2 domain-containing leukocyte phosphor protein of 76 kDa (SLP76) 3:534-535 SH2-containing phosphatase 1 (SHP-1) 3:533 SH2-containing protein tyrosine phosphatase 2 (SHP2) 3:32 SHP-2 phosphatase 3:119 SH3 see Src homology 3 (SH3) shade chloroplasts sun chloroplasts vs. 2:329-330 Shannon's information theory 4:258 SHAPE see selective 2 0 -hydroxyl acylation analyzed by primer extension (SHAPE) shared glycoprotein 130 receptors 3:27-28 Shar-Pei see Salvador (Sav) SHD see Slp homology domain (SHD) Shed syndecan-1 1:276 shedding 3:13 shelterin 1:427, 1:428, 1:428-429, 1:430 Shelterin protein complex 1:419F, 1:420 SHG signals see second harmonic generation signals (SHG signals) SHH see sonic hedgehog (SHH) Shiga toxin (STx) 2:796-797, 2:797 Shigella 2:761, 2:781 Shigella flexneri (S. flexneri) 2:791 Shine-Dalgarno (SD) sequence 1:322, 1:384-385, 1:386F, 1:545, 1:546F, 1:550 SHIP2 2:504, 2:508 SMC see smooth muscle cell (muscle cell (SMC) 3:57, 4:103 SMRT see single-molecule, real-time sequencing technology (SMRT) SMUG1 see selective monofunctional uracil-DNA glycosylase (SMUG1) SNAP see soluble NSF attachment protein (SNAP) SNAP23 see synaptosome-associated protein of 23 kDa (SNAP23) SNAP-25 1:248 SNAP REceptor see Soluble NSF Attachment Protein REceptor (SNAP REceptor) SNAREs see soluble N-ethylmaleimidesensitive factor attachment protein receptors (SNAREs) Snell's law 2:62 S-nitrosylated proteins (SNO-proteins) 1:88 Snk/Plk-akin kinase (SAK) 2:651-653 SNO-proteins see S-nitrosylated proteins (SNO-proteins) snoRNAs 3:291 snoRNAs see small nucleolar RNAs (snoRNAs) snoRNP see small nucleolar ribonucleoprotein (snoRNP) SNP see single nucleotide polymorphism (SNP) snRNA see small nuclear RNA (snRNA) snRNP see small nuclear ribonucleoproteins (snRNP) Snu114 1:497 SNX see sorting nexin (SNX) SNX3 see sorting nexin-3 (SNX3) SOCs see store-operated channels (SOCs) SOCS see suppressor of cytokine signaling (SOCS) SOCS proteins see suppressors of cytokine signaling proteins (SOCS proteins) SODD see silencer of death domains (SODD) sodium bisulfate, methylcytosine reaction with 1:31F sodium butyrate 3:790-791 sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 1:68, 1:77, 2:699 gel 1:68-69 sodium-calcium exchanger (NCX) 1:675 NCX3 1:675 sodium-potassium pump current, formulation of 4:87F SODs see superoxide dismutases (SODs) SOFI see super-resolution optical fluctuation imaging (SOFI) sog see short gastrulation (sog) SOH see SOL homology (SOH) SOL homology (SOH) 1:671",
            "latex": null,
            "type": "figure"
        },
        "FIGREF24": {
            "text": "see signal sequence (SS) SSA see single-strand annealing (SSA); stochastic simulation algorithm (SSA) SSB see single-strand DNA-binding protein (SSB) see type III secretion system (T3SS/ TTSS) T4SS see type IV secretion system (T4SS) TA sequence see tail anchor sequence (TA sequence) TAB2 see TAK1-binding protein 2 (TAB2) TACE see TNF-converting enzyme (TACE); TNFa convertase (TACE) T-acute lymphoblastic leukemia (T-ALL) 3:110, 3:562-563, 4:255 TAD see transactivating domain (TAD); transcriptional activation domain (TAD) TADG-12 see TMPRSS3 Tafazzin (TAZ) 3:101-102 TAFI see thrombin activatable fibrinolysis inhibitor (TAFI) TAG see triacylglycerol (TAG) tail anchor sequence (TA sequence) 1:597-598 tail homology domains (TH domains) 2:601 tail interacting protein of 47 kDA (TIP 47) 2:435 TAILS see terminal amine isotopic labeling of substrates (TAILS) TAK1 see transforming growth factor b-activated kinase1 (TAK1) TAK1-binding protein 2 (TAB2) 3:357-358 TALENs see transcription activator-like effector nucleases (TALENs) T-ALL see T-acute lymphoblastic leukemia (T-ALL) TALS see Taybi-Linder syndrome (TALS) TAMs see tumor-associated macrophages (TAMs) tandem affinity purification (TAP) 3:299 tandem affinity purification-mass spectrometry (TAP-MS) 4:190 tandem mass spectrometry 1:150-151 tandem mass tags (TMT) 4:169 tangential migration 2:728 Tangier disease 1:176, 1:178 TANK-binding kinase 1 (TBK1) 3:718-719 Tankyrases 3:91 TAP see tandem affinity purification (TAP) TAP1 see trasporter associated with antigen processing 1 (TAP1) Tapasin (TAP-binding protein) 3:589, 3:593-594 TAP-MS see tandem affinity purificationmass spectrometry (TAP-MS) Taq DNA polymerase 1:125 TAR see transactivation response element (TAR) TARGET see Therapeutically Applicable Research To Generate Effective Treatments (TARGET) target membrane-SNAREs (t-SNAREs) 2:459, 2:486 target of rapamycin (TOR) 1:618, 1:765, 3:3, 3:263 TOR signaling (TOS) tartrate-resistant acid phosphatase (TRAP) 1:776, 1:778 TAT see transactivator of transcription (TAT); Twin arginine translocation (TAT) TATA-binding protein (TBP) 1:477-478, 1:481 Taybi-Linder syndrome (TALS) 1:508 Tay-Sachs disease 1:767, 1:774, 1:782-783, 1:784 TAZ see Tafazzin (TAZ) tazarotene 1:706 tazarotene-induced gene 1 (TIG1) 1:707 TBDMS group see tert-butyldimethylsilyl (TBDMS) group TBI see traumatic brain injury (TBI) TBK1 see TANK-binding kinase 1 (TBK1) T-box transcription factor 5 (Tbx5) 3:102 TBP see TATA-binding protein (TBP) Tbx5 see T-box transcription factor 5 (Tbx5) TC see tip cell (TC) TCA cycle see tricarboxylic acid cycle (TCA cycle) TCAB1 see Telomerase Cajal body protein 1 (TCAB1) TcdB see C. difficile toxin B (TcdB) TCDD see tetrachlorodibenzodioxin (TCDD) T-cell immunoglobulin (TIMs) 3:734 T-cell receptor (TCR) 3:528, 3:583 ab TCR 3:530F ligands EGF receptor 3:529F ITAM motifs in multiple-chain immunoreceptors 3:530F properties 3:530-531 subunit composition, stoichiometry, and valency 3:529-530 /TCF complex 3:93-94 TCGA see The Cancer Genome Atlas (TCGA) Tcm see T central memory (Tcm) TCR see T cell antigen receptor (TCR); T cell receptor (TCR); T-cell receptor (TCR) TCs see transport complexes (TCs) TCSPC see time-correlated single photon counting (TCSPC) TD-60 see telophase disk protein 60 (TD-60) TDE see 2,2'-thiodiethanol (TDE) TDG see Thymine DNA glycosylase (TDG) TDs see topological domains (TDs) TdT see terminal deoxynucleotidyl transferase (TdT) TEA domain proteins (TEADs) 3:102 Teashirt (Tsh) 3:99 Tec kinase 2:520-522, 2:522-523 TEFs see transcription enhancer factors",
            "latex": null,
            "type": "figure"
        },
        "FIGREF25": {
            "text": "TF see tissue factor (TF); transcription factor (TF) Tf see transferrin (Tf) TFA see Trifluoroacetic acid (TFA) TFEB see transcription factor EB (TFEB) Tfh cells see T follicular helper cells (Tfh cells) Tf-HRP see transferrin coupled to horseradish peroxidase (Tf-HRP) TFIID see transcription factor IID (TFIID) TFIIH see transcription-factor IIH (TFIIH) TFPI see tissue factor pathway inhibitor (TFPI) Tfr cells see T follicular regulatory T cells (Tfr cells) TfR see transferrin receptor (TfR) TGF see transforming growth factor (TGF) TGF a see transforming growth factor a (TGF a) TGF b see transforming growth factor b (TGF b) TGFbR see transforming growth factor beta receptor (TGFbR) TGN see trans-Golgi network (TGN) TGN-derived constitutive transport 2:363 Th cells see T helper cells (Th cells) TH domains see tail homology domains (TH domains) Th17 see 17-producing helper T cell (Th17) THD see TNF homology domain (THD) The Cancer Genome Atlas (TCGA) 3:449 theory-driven approach see top-downFapproach Therapeutically Applicable Research To Generate Effective Treatments (TARGET) SEM see three-dimensional scanning electron microscopy (3D SEM) 3D SIM microscope 2:86 three-dimensional (3D) surface imaging 2:1 three-dimensional imaging 2:64 three-dimensional scanning electron microscopy (3D SEM) 2:44 data handling and segmentation 2:47-49, 2:48F imaging block face 2:45F new methods and future developments 2:49 orientation and location of region of interest 2:44-45 sample preparation 2:44 techniques 2:45-47 three prime repair exonuclease 1 (TREX1) 3:720 threonine proteases, proteasomes 1:757 threonine-serine-serine (TSS) thrombocytopenic purpura (TTP) 1:633-634, 1:717 thromboxane A2 (TxA2) 3:196 thymic stromal lympho poietin (TSLP) 3:24-25, 3:747 thymine DNA glycosylase (TDG) tilt-pair validation technique 2:7 TIM see TRAF-interacting motif (TIM) time resolution 2:113 time-correlated single photon counting (TCSPC) 2:79-80, 2:110 time-domain data 2:116-117 wide-field FLIM 2:115-116 time-lapse imaging 2:55 time-of-flight (ToF) 1:152 TIMPs see tissue inhibitors of metalloproteinases (TIMPs) TIMs see T-cell Immunoglobulin (TIMs) TINF2 see TERF1-interacting factor 2 (TINF2) tip cell (TC) 4:102, 4:111-112, 4:112 tip-stalk cell signaling 4:112F \u00fe TIPs see plus end tracking proteins ( \u00fe TIPs) tip taper 4:36, 4:38 tipranavir 1:743 TIRFM see total internal reflection fluorescence microscopy (TIRFM) TIR domain-containing adaptor protein (TIRAP) see MYD88-adaptor-like protein (MAL) KLK 1:699-700 LN macrophages 3:765 lymph node compartments and localization of macrophage populations 3:765F medullary macrophages 3:766-767 SCMs 3:765-766 macrophage subsets in spleen 3phase 3:220 scaffold 2:717-718 tissue-imaging mass spectrometry 1:152-153, 1:157 tissue-resident macrophages, specialized subsets of 3:759 repair, senescence and 3:515 tissue-resident memory T cells (T RM ) 3:568-569 tissue-type plasminogen activator (tPA) 1:717 titanium dioxide (TiO 2 ) 4:178 TI-VAMP/VAMP7 2:461-463 TJs see tight junctions (TJs) t-Loop 1:427, 1:427-428, 1:430 TLOs see tertiary lymphoid organs (TLOs) TLP1 see Tubby-likeProtein-1 (TLP1) TLR see toll-like receptors (TLR) TLS see translesion synthesis (TLS) TLSP receptors 3:26-27 TLSs see 3'-tRNA-like structures (TLSs) TM see thrombomodulin (TM) 7TM see 7-pass transmembrane (7TM) TM protein see transmembrane protein (TM protein) TM region see transmembrane region (TM region) TM segments see transmembrane segments (TM segments) TMD see trans-membrane domain (TMD) TME see transmissible mink encephalopathy (TME) TMOD3 see Tropomodulin-3 (TMOD3) TMPRSS see transmembrane protease, serine subfamily (TMPRSS) TMPRSS1 see Hepsin TMPRSS2 1:655-656 TMPRSS3 1:655-656 TMPRSS5 1:655-656 TMPRSS6 see Matriptase-2 TMPRSS10 see Corin Subfamily TMPRSS11A see HAT like-1 (HATL-1) TMPRSS11B see HAT like-5 (HATL-5) TMPRSS11D see HAT protease TMPRSS11E see DESC-1 TMPRSS11F see HAT like-4 (HATL-4) tmRNAs see transfer messenger RNA (tmRNAs) TMS see trimethylsilyl group (TMS) TMT see tandem mass tags (TMT) TMV see tobacco mosaic virus (TMV) TNC see tenascin C (TNC) TNF see tumor necrosis factor (TNF) TNF homology domain (THD) targeting of members 3:63-64 TNFa convertase (TACE) 1:639-640 TNFa-stimulated gene 6 (TSG6) 1:282 TNF-converting enzyme (TACE) 3:355 TNF-like receptor apoptosis mediating protein (TRAMP) 3:62 TNF-therapy 4:98-99 TNFR see tumor necrosis factor receptor (TNFR); tumor necrosis factors receptors (TNFR) TNFR1 superfamily see tumor necrosis factor receptor-1 (TNFR1) superfamily TNF-related apoptosis-inducing ligand (TRAIL) 3:332 TNF-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) 1:712, 3:62 TNFRSF see tumor necrosis factor receptor super family (TNFRSF) TNFs see tumor necrosis factors (TNFs) TNFSF see TNF superfamily (TNFSF) tobacco mosaic virus (TMV) 1:328-329, 1:520 Toca-1 see transducer of Cdc42-dependent actin assembly (Toca-1) ToF see time-of-flight (ToF) togaviridae, spherules producing by 2:819-820 Tokuyasu technique 2:34 TOL-1 see Toll-like receptor (TOL-1) tolerance, DCs in 3:747 tolerance maintenance/promotion 3:641 toll-like receptor (TOL-1) 2:846 toll-like receptors (TLR)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF26": {
            "text": "related kinase (VRK) VS see virological synapse (VS) vSELs see very small epithelial-like cells (vSELs) v-SNAREs see vesicle-soluble N-ethylmaleimide-sensitive factor attachment protein receptors (v-SNAREs) V-SVZ see ventricular-subventricular zone (V-SVZ) VSV see vesicular stomatitis virus (VSV) VTCs see clusters of vesicles and tubules (VTCs) VTE see venous thromboembolism (VTE) VV see vaccine virus (VV) VWA domain see von Willebrand factor A-type domain (VWA domain) vWD see von Willebrand disease (vWD) vWF see von Willebrand factor (vWF) vWF protease see von Willebrand factor protease (vWF protease) VZ see ventricular zone (VZ)",
            "latex": null,
            "type": "figure"
        },
        "TABREF3": {
            "text": "CaM kinase-kinase (CaMKK) 3:166 CaM see calmodulin (CaM) CAM see chorioallantoic membrane (CAM) CamK see calmodulin kinase (CamK) CaMKI see CaM kinase I (CaMKI) CaMKII see CaM kinase II (CaMKII) CaMKK see CaM kinase-kinase (CaMKK)",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "EF-Tu see elongation factors Tu (EF-Tu) EG see embryonic germ cells (EG) ER protein quality control (ERQC) 2:529 ER protein-folding homeostasis 2:529 ER see endoplasmic reticulum (ER) ER/Golgi-dependent pathway 2:520 ER71 see ETS-related 71 (ER71) ERAD see endoplasmic reticulum-associated ES see E-surface (ES) ES cells see embryonic stem cells (ES cells) ES27 see expansion segment 27 (ES27) ESC see embryonic stem cell (ESC) ESCC see esophageal squamous cell carcinoma (ESCC) bacterial clamps in 1:400, 1:401F biosynthetic pathway for phospholipids in 1:163F C-family polymerase of 1:400 foreign lipids synthesis in 1:164F DnaB helicase 1:404 Pol III 1:398 polymerase release from Okazaki fragment 1:410 replisome 1:408 Shine-Dalgarno sequence in 1:341-342 ESCR7 see encapsulated SCR7 (ESCR7) ESCRT see endosomal sorting complexes required for transport (ESCRT) ESCRT-0 see STAM-Hrs complex ESCRT-based cell division 2:590F, 2:592 ESE see early sorting endosome (ESE) E-selectin ligand-1 (ESL-1) 3:751 ESI see electrospray ion source (ESI); electrospray ionization (ESI) ESL-1 see E-selectin ligand-1 (ESL-1) esophageal squamous cell carcinoma (ESCC) 3:158 ESP-1 see testisin essential autophagy (Atg) genes 1:764-765 essential cellular functions 4:72 essential light chain (ELC) 2:597 essential thrombocythemia (ET) 3:146 estradiol 1:178-179 ESTs see expressed sequence tags (ESTs) E-surface (ES) 2:39 cells 1:512-513, 1:514 E-Syt2 see extended-Synaptotagmin 2 (E-Syt2) ET see essential thrombocythemia (ET) ET-1 see endothelin-1 (ET-1) ETD see electron-transfer dissociation (ETD) ETEC see enterotoxigenic Escherichia coli (ETEC) ether protecting groups 1:42-43 2-cyanoethyl group 1:43 tert-butyldimethylsilyl group 1:42-43 ethyl isopropyl amiloride (EIPA) 2:762 ethylenediaminetetra-acetate (EDTA) 4:178 ETI see effector-triggered immunity (ETI) etioplast 2:324 ETS see externally transcribed spacer (ETS) Etv2 see ETS-related 71 (ER71) eubacteria 1:160, 1:160-161 in vivo dynamics and behavior 1:484 Pol II C-Terminal Domain 1:483 supercoiling 1:484 termination of transcription 1:483 eukaryotic translation factors 1:527-529 ETS-related 71 (ER71) 4:103 extracellular cues transmission 3:413 extracellular domain (ECD) 3:30-31, 3:183 extracellular matrix (ECM) 1:555, 1:562,",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "FFI see fatal familial insomnia (FFI) FG see phenylalanine-glycine (FG) FGF receptor substrate 2 (FRS2) 4:105-106 FGF see fibroblast growth factor (FGF) FGF2 3:790-791 FGF2-Y81pCMF see phosphomimetic substitution in FGF2 (FGF2-Y81pCMF) FGFR see fibroblast growth factor receptor (FGFR) FGF-VEGF-Ang-PDGF networking 4:108-109 FH domains see formin homology domains (FH domains) FH1 see formin homology domains 1 (FH1) FHL see familial hemophagocytic lymphohistiocytosis (FHL) FHV see Flock House virus (FHV) fI membrane-attack complex domain (FIMAC domain) 1:729 FIB see focused ion beam (FIB) Fibril-associated Collagens with Interrupted 151C compartment 2:168-169 FIH-1 see factor inhibiting HIF-1 (FIH-1) FIIND see function-to-find domain (FIIND) filamentous actin (F-actin) 2:597, 4:19",
            "latex": null,
            "type": "table"
        },
        "TABREF19": {
            "text": "PLCb family 3:155-156 PLCg family 3:156-157 PLCd family 3:153-155 PLCe1 family 3:157-158 PLCz1 family 3:158-159 PLCZ family 3:158 phosphoinositide 1:198-199, 1:199 phosphoinositide 3-kinase (PI3K) in autophagy regulation 2:515-516, 2:516F binding domains 2:507T coordination 2:195-196 in endosomal compartment 2:510-512 in Golgi trafficking 2:512-513, 2:514F at membrane-cytosol interface 2:505 structures, mechanisms, and mechanisms of H \u00fe transfer 1:303 pathways of proton uptake into membrane 1:303-304 proton donation to p-side aqueous phase Phox Bem1p (PB1) 1:92 phox homolog domain (PX domain) 3:128 phox homology (PX) domain 2:475 phoxdomain-containing domains (PX-BAR domains) 2:491 PHPV see persistent hyperplastic primary vitreous (PHPV) PHS see PTEN hamartomatous syndromes (PHS) phylogenetics 4:154, 4:157-158 phyotohormones see plant hormones physical stresses 3:123-124, 3:124 physiologic inflammation 3:374 physiological lipid transport, Class B SRs PI3K 3:128 signaling in human disorders 3:133-134 PI3KC see class I PI3-kinase (PI3KC) PI3KC2A/PI3KC2a see class II PI3-kinase 823F membrane tubes and DMVs generation by 2:822 PICS see protease cleavage site specificity (PICS) PICS see proteomic identification of cleavage site specificity (PICS) PicTar 1:365 PIDD see p53-induced death domain protein (PIDD) pigment synthesis 2:329 pIgR see polymeric IgA receptor (pIgR) PIK1 see class III PI4-kinase (PIK1) PIK-1 see Pelle and IL-1R-associatedkinases (PIK-1) PIKfyve/PIP5K3 2:504 PI-kinases 1:204-205 PIN efflux proteins 4:129, 4:130-131 ping pong mechanisms 1:16-17, 1:17 PinkBAR 2:497 pinocytosis 2:758 solute flow during 2:759 PIP2 see PI-4,5-bisphosphate (PIP2) PIP5K see PI-4-phosphate-5-kinase (PIP5K) PI-phosphatases 1:204-205 PIPKIs see phosphatidylinositol phosphate kinases (PIPKIs) PI-PLC see phosphatidylinositol-specific phospholipase C (PI-PLC) PIPs see phosphatidylinositol phosphatases (PIPs); phosphoinositide phosphates (PIPs) piRISC see piRNA-silencing complex (piRISC) piRNA see Piwi-interacting RNA (piRNA) piRNA-silencing complex (piRISC) 3:322 PIs see phosphoinositides (PIs) pivaloyloxymethyl (PivOM) group 1:46 pixel negative values 2:90-91 pk see Prickle (pk) PKA see cAMP-dependent protein kinase (PKA); protein kinase A (PKA) PKC see protein kinase C (PKC) PKCe see protein kinase Ce (PKCe) PKD see polycystic kidney disease (PKD); protein kinase D (PKD) PKG see cGMP-dependent protein kinase (PKG) Pkp see plakophilins (Pkp) PKR-related ER kinase (PERK) 2:529 PLA2 see phospholipase A2 (PLA2) placental growth factor (PlGF) 4:106 PLAD see pre-ligand binding assembly PlGF see placental growth factor (PlGF) pLGIC see pentameric ligand-gated ion channels (pLGIC) PLIs see protein-lipid interactions (PLIs) Plk1 see polo-like kinase 1 (Plk1) Plk1-interactingcheckpointhelicase (PICH) 3:501 PLK4 see polo-like kinase 4 (PLK4) PLP see pericentrin-like protein (PLP) PLS see Papillon-Lef\u00e8vre syndrome (PLS) PLT protocol see progressive-lowering of temperature protocol (PLT protocol) plunge freezing 2:22-23, 2:23F, 2:24F, 2:24 pluripotency 3:819 pluripotent cells 3:819-822 cell-based regenerative therapy, tools for 3:820-821 clinical trials and contributions 3:821 determining cell fates and disease states PM see plasma membrane (PM) PM optical fiber see polarizationmaintaining optical fiber (PM optical fiber) PMA see phorbol myristate acetate (PMA) PMCA see plasma membrane calcium ATPase (PMCA) PMF see peptide mass fingerprinting (PMF) pMHC see peptide bound to major histocompatibility complex molecule (pMHC) p-MHC see peptides-major histocompatibility molecules (p-MHC) pMHC-I see peptide MHC class I complexes (pMHC-I) PML see promyelocytic leukemia (PML) PML-NB see promyelocytic-leukemia nuclear body (PML-NB) PMNs see polymorphonuclear cells (PMNs) PMTs see photo-multiplier tubes (PMTs) PNAd see peripheral lymph node addressin (PNAd) PNKP see polynucleotide kinase phosphatase (PNKP) PNPase see polynucleotide phosphorylase (PNPase) Pnr production see Pannier production (Pnr production) PNS see peripheral nervous system (PNS) podocalyxin (PODXL) 4:112 podosome 3:637-638, 3:644 PODXL see podocalyxin (PODXL) POFUT2 see protein O-fucosyltransferase 2 poly(A) tail 1:343, 1:344, 3:307 poly(A)-binding protein (PABP) 3:317 poly(A)-nuclease 2 (PAN2) 1:346 poly(A)-specific ribonuclease (PARN) 1:346 poly-ADP ribose polymerase (PARP) 1:465, 3:573-574 PARP-1 1:436, 2:614 polyamine catabolism 2:254 polybrene s 1:77-78 poly C binding protein 2 (PCBP2) 3:313 polychlorinated biphenyl (PCB) 2:276 polycistronic mRNA 1:341, 1:342 polycomb group genes (PcG) 3:438 Polycomb repressive complex (PRC) 1:484 polycystic kidney disease (PKD) 2:748 polycythemia vera (PCV) 3:146 polydactyly 3:79, 3:80 polyethylene glycol (PEG) 1:125-126 polyketide synthase 1:14 polyketides 1:156 polymerase 1:122, 1:418, 1:439, 1:520,",
            "latex": null,
            "type": "table"
        },
        "TABREF20": {
            "text": "pre-autophagosomal structure see phagophore assembly site (PAS) precision genome editing 1:515 precursor miRNA (pre-miRNA) 1:354, 1:358, 1:359, 1:360, 1:360-361 cleavage by Dicer 1:355-358 Drosha cleavage 1:355 transportation by Exportin-5/Ran-GTP complex 1:355 precursor RNA processing proteins (Prps) 1:503-504 precursor rRNA, cleavage and folding of 3:289-291 precursor with cDCs (pre-DC) 3:743 pre-DC see precursor with cDCs (pre-DC) pre-docking process 2:380-381 preembedding labeling 2:36-37 pre-fractionation 4:167 pregnancy, changes in gut microbiome in pre-integration complex (PIC) see preinitiation complex (PIC) prekallikrein (preKLK) 1:699 pre-ligand binding assembly domain (PLAD) 3:61-62 premature stop codon (PTC) 3:317 pre-miR-451 1:359 pre-miRNA see precursor miRNA (pre-miRNA) pre-mRNA splicing 1:377, 1:495-502, PRIs see protein-RNA interactions (PRIs) Prize-collecting Steiner approaches 4:215F Prize-collecting Steiner Forest 4:212T, 4:215-216 Prize-collecting Steiner Tree (PCST) 4:212T, 4:215-216, 4:216 Prize-collecting Steiner Tree methods (PCST methods) 4:215-216, 4:215F PRL see prolactin (PRL)",
            "latex": null,
            "type": "table"
        },
        "TABREF21": {
            "text": "inhibitors 1:591-592, 1:592 protection of telomeres protein 1 (POT1) 1:420, 1:427 protective antigen (PA) 2:795 proteins, isolation/purification of 1:66 protein structure 1:91-92 protein engineering 1:124, 1:318 altered function 1:124 site-selective conjugation 1:125-126 stability 1:124-125 oxidative 1:125 pH 1:125 thermal 1:125 protein family 1:396 protein fold 1:396 protein folding and assembly in ER 1:538-540 protein folding diseases 1:115-121 cell specificity and susceptibility 1:118 cellular transfer of aggregates on toxic fragments 1:117-118 clearance pathways of aggregates autophagy pathway 1:117 cellular UPS 1:116-117 effects of protein products on protein homeostasis 1:116 genetic basis of HD and ALS 1:116 potential treatments and therapies 1:119 symptoms and treatments of disease protein p35 from the cowpox virus 3:332 protein phosphatase (PP) 2:663 protein phosphatase 1 (PP1) 1:290, 1:291-292, 1:292, 2:531-532, 2:584 Protein phosphatase 2A (PP2A) 3:100, 3:132, 3:343 protein phosphorylation 1:528F protein quality control 1:596, 1:606 protein quantitiative trait loci analysis (pQTL analysis) 4:171 protein regulator of cytokinesis-1 (PRC1) 80S initiation complex 1:528F, 1:530F A, P, and E sites 1:525, 1:531 bacterial 1:384, 1:385F beyond first ribosome 1:531 PSA see prostate-specificantigen (PSA) PSA-NCAM see polysialic acid-neuronal cell adhesion molecule (PSA-NCAM) PSCK3 see Furin (PCSK3) PSD see postsynaptic density (PSD) PSD95, Dlg1 and zo-1 domain (PDZ PSF see point spread function (PSF) PSGL-1 see P-selectin glycoprotein ligand 1 (PSGL-1) PSI-MI see Proteomics Standards Initative-Molecular Interactions (PSI-MI) PSM see presomitic mesoderm (PSM) pSMAC see peripheral supra-molecular activation cluster (pSMAC); peripheral SMAC (pSMAC) PSMIs see protein-small molecule interactions (PSMIs) PSP see proteolytic signature peptides (PSP) PSR see PS receptor (PSR) PSTPIP1 see proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1) P-surface (PS) 2:39 psychosine 1:184 PTAs see peripheral tissue antigens (PTAs) PTB domain see phosphotyrosine binding domain (PTB domain) PTC see premature stop codon (PTC) PTCH see Patched (PTCH) PTEN see phosphatase and tensin homolog (PTEN) PtdIns 3P see phosphatidyl inositol 3-phosphate (PtdIns 3P) PtdIns see phosphatidylinositol (PtdIns) PtdIns-3-phosphate (PtdIns3P) 3:128 PtdIns4P see PtdIns-4-phosphate (PtdIns4P) PtdIns-4-phosphate (PtdIns4P) 3:128 P-TEF-b see positive-transcriptional elongation factor b (P-TEF-b) PTEN hamartomatous syndromes (PHS) 3:419 PTEN homolog see phosphatase and tensin homolog (PTEN homolog) PTHR see parathyroid hormone receptor (PTHR) PTK see protein tyrosine kinase (PTK) PTLs see Photoswitchable tethered ligands (PTLs) PTMs see posttranslational modifications (PTMs) PTPC see permeability transition pore complex (PTPC) PTPN14 see tyrosine-protein phosphatase non-receptor type 14 (PTPN14) PTPs see protein tyrosine phosphatases (PTPs) PTS see phospho-transferase system (PTS) PTX see pertussis toxin (PTX) pullanase 1:125 pulling forces 3:664-665 pulmonary embolism (PE) 1:718-719 pulsed Q-dissociation (PQD) 4:182 puncta 2:744-745 punctin-1 1:633 purified COPI-coated vesicles 2:356 purine catabolism 2:254 PV see polio-virus (PV) PWD see phosphoglucan water dikinase (PWD) PX domain see phox homolog domain (PX domain) PX-BAR domains see phoxdomaincontaining domains (PX-BAR domains) PX-containing protein SNX16 2:203 PYD see pyrin domain (PYD) pyrin and HIN domain (PYHIN) 3:719-720 PYHIN1 3:719-720 pyrin domain (PYD) 3:714 pyrin domain only protein 3 (POP3) QAE see quaternary aminoethyl (QAE) QbD see quality-by-design (QbD) QIT-TOF see quadrupole iontraptime-offlight (QIT-TOF) QSAR see quantitative structure activity relationships (QSAR) QTL analysis see quantitative trait linkage analysis (QTL analysis) quadratic programming 4:212T quadrupole iontraptime-of-flight (QIT-TOF) 1:155 quality assessment and benchmarking 4:248 quality control 2:156-157, 2:163, 2:164, 3:404, 3:408 mechanisms for ribosome assembly 3:303 quality control code 1:599, 1:601 quality-by-design (QbD) 1:136 quantitative phosphoproteomics 4:182 intrinsic modifications in aged 3:779-780 saturation irradiance 2:77-78 Sav see Salvador (Sav) Sav1 see Salvador 1 (Sav1) SAX see strong anion exchange (SAX) SAXS see small-angle X-ray scattering (SAXS) SBEs see SMAD binding elements (SBEs) SBF-SEM see serial block face scanning electron microscopy (SBF-SEM) SBML see systems biology markup language (SBML) SCA-1 see stem cell antigen 1 (SCA-1) beam-specimen interactions 2:15-16 in cell biology 2:21construction 2:14 critical point drying 2:17 cryoscanning EM 2:18 environmental SEM 2:18 freeze etching 2:20 history 2:16-17 image formation 2:16 labeling for 2:17-18 and nuclear envelope 2:20-21 scanning specimen 2:14-15 serial block face imaging 2:18 specimen preparation for 2:17 sputter coating 2:17 and TEM merging 2:18-19 exposing subsurface detail 2:19 SEM of subcellular detail 2:19-20 TEM vs. 2:14 SCAP see SREBP cleavage activating protein (SCAP) scar formation 3:216 blood clotting and inflammation 3:216-219, 3:217F phase of new tissue formation 3:219 tissue remodeling phase 3:220 SCAR see suppressor of cAR (SCAR) scavenger receptor A (SR-A) 3:763 scavenger receptor cysteine rich (SRCR) SR-specific domains share ancient origins",
            "latex": null,
            "type": "table"
        },
        "TABREF22": {
            "text": "SOLiD technology see sequencing by oligonucleotide ligation and detection technology (SOLiD technology) solubility-enhancing protein domains 1:57T soluble APP fragment (sAPPb) 1:696 soluble chemoattractants 2:724 soluble GCs (sGCs) 3:56, 3:56-57 soluble hydrolases 1:613 soluble monomers 2:409-410 soluble N-ethylmaleimide-sensitive factor vesicle tether interactions with small GTPases and 2:485-486 soluble NSF attachment protein (SNAP) 3:752 receptor 2:796 SNAP-23 2:225-226 SNAP-25 2:298 Soluble NSF Attachment Protein REceptor (SNAP REceptor) 1:616 soluble TNF (sTNF) 3:62-63 soluble VEGFR1 (sVEGFR1/sFlt1) 4:111-112 solvent 1:109 somatic cell nuclear transfer (SCNT) 3:819 somatic centrosomes 2:656 somatic hyper-mutation (SHM) 3:530-531, 3:552 somatic mutations 1:360, 1:507-508, 1:508 somatic single-nucleotide variants (SSNVs) 3:673-674 somatomedin-B (SMB) 3:728 somitogenesis, multiscale modeling of 4:128, 4:129F SON 3:819 son of sevenless protein (SOS protein) 3:119 sonic hedgehog (SHH) 1:369, 3:2, 3:76, 3:343 sonication 1:66, 1:69 SOP see sensory organ precursors (SOP) S-Opa1 2:283-284 SorL1 protein 2:478 SorLA see SorL1 protein Sorsby fundus dystrophy (SFD) 1:712-713 sorting 2:175-176 sorting endosome 2:193 sorting nexin (SNX) 2:196, 2:410, 2:475, sorting signals 2:427-428, 2:450 SOS protein see son of sevenless protein (SOS protein) Sox2 see SRY-box 2 (Sox2) SOX9 see sex-determining region Y-box 9 (SOX9) SP see sulfopropyl (SP) spacing 3:193-194 SPADE see Spanning-tree progression analysis of density-normalized events (SPADE) Spanning-tree progression analysis of density-normalized events (SPADE) 4:223 SPARC 2:700 sparsely populated states of proteins and complexes 1:103 lifetime line broadening and DEST 1:104-105 PRE 1:103-104 principal NMR methods 1:103 relaxation dispersion spectroscopy",
            "latex": null,
            "type": "table"
        },
        "TABREF23": {
            "text": "TEFs) TEK see Tie2 receptor telomerase 1:420-421, 1:422, 1:423, 1:430 Cajal body (sca) RNAs 1:422 mammalian Shelterin complex 1:421, 1:421F RNA 1:422-423 telomerase Cajal body protein 1 (TCAB1) 1:422 telomerase reverse transcriptase (TERT) 1:420-421, 1:421-422 Telomerase Cajal body protein 1 (TCAB1) 1:422 telomerase reverse transcriptase (TERT) 1:420-421, 1:421-422, 1:421-422 telomerase reverse transcriptase protein (TERT) 1:430 telomerase RNA component (TERC) 1:430 telomere repeat-containing RNA (TERRA) 1:430 telomere sister chromatid exchange (T-SCE) 1:431 telomere(s) 1:2-3, 1:418, 1:426, 3:512, 3:513 alternative lengthening 1:423 crisis 1:431 DNA 1:427 end-replication problem 1:418-419, 1:419F DNA polymerases synthesize 1:418-419 length/shortening rate 1:419 molecular events 1:426-427 physiology noncancer telomere-related diseases 1:432-433 senescence and telomere crisis 1:431 telomeres in cancer cells 1:431-432 telomere secondary structure 1:427 syndromes of short telomeres 1:423 telomeric DNA 1:419 telomeric proteins 1:419-420 telomeric repeat-binding factors 1 and 2 1:420 telomeric repeat-containing RNA (TERRA) 1:420 telomeric repeat-containing RNA 1:420 in yeast 1:420 telomeric repeat-binding factor 1 (TRF1) 1:420, 1:427 telomeric repeat-binding factor 2 (TRF2) 1:420, 1:427 telomeric repeat-binding factor 2-interacting protein 1 (TERF2IP) 1:427 telophase 3:481 CPC during 3:475 telophase disk protein 60 (TD-60) 3:469 Tem see T effector memory (Tem) TEM see transmission electron microscope (TEM) template DNA synthesis template-dependent 1:451 template-independent 1:451 strand 1:471, 1:472 temporal regulation of transgenes 1:513-514 temporal sensing 4:5-6 tenascin C (TNC) 3:63-64 tener-taxis 3:637-638 TERC see telomerase RNA component (TERC) TERF1-interacting factor 2 (TINF2) 1:427 TERF2IP see telomeric repeat-binding factor termination codons 1:310, 1:324, 1:531 termination-reinitiation 1:522F, 1:523-524 terminome 1:569 terminomics 1:569 TERRA see telomere repeat-containing RNA (TERRA) TERT see telomerase reverse transcriptase (TERT); telomerase reverse transcriptase protein (TERT) tert-butyldimethylsilyl (TBDMS)group 1:42-43, 1:44 tertiary granules 2:770, 3:751 tertiary lymphoid organs (TLOs) 3:616, 3:619 stromal cells in induced 3:619 testisin 1:654 testosterone 1:178-179 tetanus neurotoxin 2:796 tether repeats (TRs) 2:335-336 tetherin restriction factor 2:836 tethering 1:551F, 1:765, 2:412, 2:436, 2:437, 2:485, 3:751 tethers 2:171, 2:355 TetR see tetracycline repressor (TetR) tetrachlorodibenzodioxin (TCDD) 2:276 tetracycline repressor (TetR) 1:513-514 tetratricopeptide repeats (TPRs) 2:667 tetratricopeptide-rich regions (TPR) 3:704 text-mining approaches 4:248",
            "latex": null,
            "type": "table"
        },
        "TABREF24": {
            "text": "TOP see terminal oligopyrimidine (TOP) topoisomerases 1:396-397, 1:406F topological domains (TDs) 3:789 TOR see target of rapamycin (TOR) TORC1 see target of rapamycin complex 1 TSE see transmissible spongiform encephalopathy (TSE) TSG6 see TNFa-stimulated gene 6 (TSG6) Tsh see Teashirt (Tsh) TSLP receptor (TSLPR) 3:27 TSLP see thymic stromal lympho poietin (TSLP) TSLPR see TSLP receptor (TSLPR) tSNARE Pep12 2:204 t-SNAREs see target membrane-SNAREs (t-SNAREs) TSP1 see thrombospondin-1 (TSP1) TSRs see thrombospondin type 1 repeats (TSRs) TSS see threonine-serine-serine (TSS); transcription start sites (TSS); transcriptional start site (TSS) TTC19 see tetratricopeptide repeat domain protein 19 (TTC19) TTD see trichothiodystrophy (TTD) TTF-1 see thyroidtranscriptionfactor-1 (TTF-1) TTF1 see transcription termination factor 1 (TTF1) TTP see thrombotic thrombocytopenic purpura (TTP); tristetraprolin (TTP) TTSPs see type II transmembrane serine proteases (TTSPs) TTSS see type III secretion system (T3SS/ TTSS) T-tubules 2:679-680, 2:680F Tubby-like Protein-1 (TLP1) 3:375 Tubby-like protein 3 (TULP3) 2:667 tuberculosis 2:777 tuberin see tuberous sclerosis 1 (Tsc1) tuberous sclerosis complex (TSC) 3:246-247, 3:247 TSC1 3:130 TSC2 3:130 tuberous sclerosis 1 (Tsc1) 3:815 tubules 2:367 tubulin 2:540-541 association between G proteins and tubulin 3:52-53 tubulin-like TubZ 2:592-593 TULP3 see Tubby-like protein 3 (TULP3) tumor cells 3:335, 3:335-336, 3:338-339 tumor heterogeneity 3:807 tumor initiating cell (TIC) 3:807, 4:208F tumor microenvironment 4:142-143, TNF inhibitors 3:360, 3:361F TNF signaling regulation 3:358-359 TNF-induced activation of MAPK pathways 3:359 TNF-induced TNFR signaling 3:356-357 TNFRSF members 3:356T TNFSF 3:354-355 members 3:355T tumor necrosis factor receptor (TNFR) 1:708, 3:354 and ligand complex 3:357F signaling pathways 3:359F TNFR-induced cell death 3:358 TNFR-induced NF-kB activation tumor necrosis factor receptor-1 (TNFR1) superfamily 3:327-328 tumor necrosis factor receptor-associated factors (TRAFs) 1:691, 3:28, 3:62, 3:70, 3:712-714, 3:770-771 TRAF2 2:530, 3:392, 4:221-222 TRAF6 2:530 tumor necrosis factor-related apoptosis ligand (TRAIL) 1:687, 3:63-64, 3:70-71, 4:219 tumor necrosis factors (TNFs) 3:1-2, 3:4 tumor necrosis factors receptors (TNFR) 3:61-66, 3:61 clinical targeting of TNFSF and TNFRSF members 3:63-64 double-edged sword in cancer 3:63 ligand-receptor interaction structural basis Turnip yellow mosaic virus (TYMV) 1:328F, 1:329 12/23 rule 3:557-558, 3:559F twin arginine translocation (TAT) 1:57 Twist1 factor 3:224, 3:225 Twist2 factor 3:224 two-color cross-correlation spectroscopy 2:102-103 two-dimensional gel electrophoresis (2-DE) 1:571 2D-kinetics, mechanical assays to measuring 3:661 two-dimensional scanning electron microscopy (2D SEM) 2:47F two-photon excitation (2PE) 2:80, 2:101 two-photon microcopy 2:68-69 TxA2 see thromboxane A2 (TxA2) TXNIP expression see thioredoxininteracting protein expression (TXNIP expression) TYMV see Turnip yellow mosaic virus (TYMV) type I cells 3:70, 3:343 type-I inositol 4-phosphatase (Inpp4a) 2:505 type 1 IRESs 3:309 type I transmembrane serine proteases 1:654 type 2 diabetes mellitus (T2DM) 2:806, 3:133, 3:419-420 type-II inositol 4-phosphatase (Inpp4b) 2:505 type 2 IRESs 3:309 type II natural killer T-lymphocytes (NKT) follicular lymphocytes 1:773 type II transmembrane serine proteases (TTSPs) 1:650, 1:654 Corin Subfamily 1:656-657 HAT/DESC subfamily 1:654-655 Hepsin/TMPRSS Subfamily 1:655-656 Matriptase Subfamily 1:656 type II transmembrane trypsin-like serine proteases 1:756-757 type 3 HCV-like IRESs 3:309 type III secretion system (T3SS/TTSS) 2:776, 3:717 type 4 Dicistroviridae IGR IRESs 3:309-310, 3:311F type IV secretion system (T4SS) 2:777 type 5 purple acid phosphatase (Acp5) 1:776 type B cells 4:135-136, 4:137-138 type C phospholipases (PLC) 2:790 Tyr see tyrosinase (Tyr); tyrosine (Tyr) tyr kinase receptors 2:724 tyr-kinase domain 2:491 Tyr-Leu-Leu (YLL) 2:478 tyrosinase (Tyr) 2:237 tyrosinase-related protein 1 (Tyrp1) 2:237 tyrosine (Tyr) 2:491 tyrosine kinase receptor (TrkA) 2:211 vps26 (continued) Vps27, Hrs, and STAM (VHS) 2:453 VPS29 protein 2:475, 2:476 VPS35 protein 2:475, 2:475-476 VPS35-VPS26 interaction 2:475-476 VRK see Vaccinia-",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "nerve growth factor (NGF) 2:211, 3:51-52, 3:235, 4 :223-224 inducing neurite outgrowth through G protein 3:52 association between G proteins and tubulin 3:52-53 3:479-480 nuclear envelope transmembrane proteins (NET proteins) see inner nuclear membrane proteins (INM proteins) nuclear excision repair pathway (NER pathway) 3:462-463, 3:464F nuclear export 3:300, 3:302 pre-ribosomal particles 3:299-301 nuclear export sequences (NES) 3:90F, 3:93 nuclear export signal (NES) 2:313, 2:320, 3:172, 3:300, 4:218, 4 :222 nuclear factor erythroid 2 (NF-E2) 2:531 nuclear factor kappa B (NFkB) 1:757, 2:530, 3:6, 3:70, 3:130, 3:224, 3:355-356, 3:520, 3:580, 3:710, 3:770-771, 4 :99 B-and T-cell receptor pathways 3:583 BAFF receptor pathways 3:583 CD28 receptor pathway 3:583 CD40 3:583 core NF-kB signaling gene and protein names 3:581T dimers 3:580-581 expression and knockout mice 3:581 c-rel KO mice 3:582 immune defects 3:583T nfkb1 KO mice 3:581 nfkb2 KO mice 3:581-582 rela KO mice 3:582 relb KO mice 3:582 human immune cell viruses 3:585 in innate immunity 3:583-584, 3:584T misregulation in human immune diseases 3:584-585 pathways 3:392-393 canonical and noncanonical 3:393F signaling 1:428, 1:708-709 superfamily proteins 3:582F for therapy in immune diseases 3:585-586 TNFR-induced NF-kB activation 3:357-358 nuclear factor kappa-light-chain-enhancer of activated B cells (NF-KB) activation dynamics 3:667 nuclear factor of activated T cells (NFAT) 3:6, 3:167, 3:355-356, 3:573, 4 :105-106 domain structure 3:573 functions in T cells 3:575 NFAT-regulated transcription 3:574-575 regulation of activation 3:573-574, 3:574F and T cell tolerance 3:575-576, 3:576F nuclear genomes 1:312-313, 1:380 nuclear import machinery 2:814-815, 3 :439-440 nuclear lamina 2:569, 2:573, 2:576 nuclear localization sequences (NLS) 3:90F, 3:92-93, 3:94F nuclear localization signal (NLS) 2:312-313, 2:320, 3:172, 3:236, 4:218, 4 :222 nuclear magnetic resonance (NMR) spectroscopy 1:93, 1:98 bacterial phosphotransferase system, structural proteomics of 1:101-103 experimental and computational considerations 1:99 computational methods 1:100-101 intermolecular distance restraints 1:99 orientational restraints 1:100 paramagnetic-based distance restraints 1:99-100 sources of distance information 1:100 exploring sparsely populated states of proteins and complexes 1:103 lifetime line broadening and DEST 1:104-105 PRE 1:103-104 principal NMR methods 1:103 relaxation dispersion spectroscopy 1:104 relevance to cell biology 1:105 historical perspective 1:98 NMR spectroscopy in structural and cell biology 1:99 solution structure determination of macromolecules 1:98 structure determination 1:98-99 nuclear migration 2:625 nuclear migration one (Num1) 1:240 nuclear mitotic apparatus (NuMA) 2:625, 3:480-481 nuclear organization 1:311-318 see also nuclear envelope (NE) nuclear overhauser enhancement (NOE) 1:98, 1:98-99 nuclear pore complex (NPC) 4:188, 4:212, 4:213, 4:214, near-term challenges 4:221 technical limitations 4:220-221 single-chain Fv (scFv) 1:142-143 single-headed myosins 2:601 single-molecule, real-time sequencing technology (SMRT) 4:160, 4:161 single-molecule detection (SMD) 2:115 single-particle electron cryo-microscopy (cryoEM) conformational changes of a molecular machine, delineating 2:11 density maps, resolution of 2:7-8 frozen, hydrated specimen preparation for 2:6 high-resolution structures 2:9 identifying different populations within a heterogeneous sample 2:9-11 image acquisition 2:6 image processing in 2:6-7 of macromolecular complexes 2:5-13 model building and model validation 2:8-9 preferred orientation 2:6, 2:7 sample consideration for 2:5-6 single-particle tracking ( 3:462-463 XFE (XPF-ERCC1) progeria 1:440 XIAP see X-linked inhibitor of apoptosis protein (XIAP) XIST 1:369 X-linked EDA-A2 receptor (XEDAR) 3:62 X-linked Emery-Dreifuss muscular dystrophy (X-EDMD) 2:315 X-linked IAP (XIAP) 3:331 X-linked inhibitor of apoptosis protein (XIAP) 3:391, 3:69-70, 3:343 X-linked lymphoproliferative syndrome type-2 (XLP2) 3:391 XLP2 see X-linked lymphoproliferative syndrome type-2 (XLP2) XMAP215 4:40 XP see xeroderma pigmentosum (XP) XPC-HR23B-CETN2 1:436-437 X-ray cross-complementing protein 1 (XRCC1) 1:442-443 XRCC1 see X-ray cross-complementing protein 1 (XRCC1) xWnt8 3:87-88, 3 ",
            "cite_spans": [
                {
                    "start": 33,
                    "end": 50,
                    "text": "3:51-52, 3:235, 4",
                    "ref_id": null
                },
                {
                    "start": 363,
                    "end": 368,
                    "text": "3:302",
                    "ref_id": null
                },
                {
                    "start": 488,
                    "end": 510,
                    "text": "3:172, 3:300, 4:218, 4",
                    "ref_id": null
                },
                {
                    "start": 601,
                    "end": 670,
                    "text": "3:6, 3:70, 3:130, 3:224, 3:355-356, 3:520, 3:580, 3:710, 3:770-771, 4",
                    "ref_id": null
                },
                {
                    "start": 1454,
                    "end": 1485,
                    "text": "3:6, 3:167, 3:355-356, 3:573, 4",
                    "ref_id": null
                },
                {
                    "start": 1735,
                    "end": 1736,
                    "text": "3",
                    "ref_id": null
                },
                {
                    "start": 1892,
                    "end": 1914,
                    "text": "3:172, 3:236, 4:218, 4",
                    "ref_id": null
                },
                {
                    "start": 1947,
                    "end": 1952,
                    "text": "(NMR)",
                    "ref_id": null
                },
                {
                    "start": 2887,
                    "end": 2892,
                    "text": "(NOE)",
                    "ref_id": null
                },
                {
                    "start": 2928,
                    "end": 2933,
                    "text": "(NPC)",
                    "ref_id": null
                },
                {
                    "start": 2934,
                    "end": 2940,
                    "text": "4:188,",
                    "ref_id": null
                },
                {
                    "start": 2941,
                    "end": 2947,
                    "text": "4:212,",
                    "ref_id": null
                },
                {
                    "start": 2948,
                    "end": 2954,
                    "text": "4:213,",
                    "ref_id": null
                },
                {
                    "start": 2955,
                    "end": 2961,
                    "text": "4:214,",
                    "ref_id": null
                },
                {
                    "start": 4313,
                    "end": 4314,
                    "text": "3",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}